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The continuing threats from viral infectious diseases highlight the 
need for new tools to study viral interactions with host cells. 
Understanding how these viruses interact and respond to their 
environment can help predict outbreaks, shed insight on the most likely 
strains to emerge, and determine which viruses have the potential to 
cause significant human illness.  Animal studies provide a wealth of 
information, but the interpretation of results is confounded by the large 
number of uncontrolled or unknown variables in complex living systems.  
In contrast, traditional tissue culture approaches have provided 
investigators a valuable platform with a high degree of experimental 
control and flexibility, but the static nature of flask-based cell culture 
makes it difficult to study viral evolution.  Serial passaging introduces 
un-physiological perturbations to cell and virus populations by 
drastically reducing the number of species with each passage.  Low copy, 
high fitness viral variants maybe eliminated, while in vivo these variants 
vii 
would be essential in determining the virus’ evolutionary fate.  Bridging 
technologies are urgently needed to mitigate the unrealistic dynamics in 
static flask-based cultures, and the complexity and expense of in vivo 
experiments. 
This thesis details the development of a continuous perfusion 
platform capable of more closely mimicking in vivo cell-virus dynamics, 
while surpassing the experimental control and flexibility of standard cell 
culture.  First, a microfluidic flow through acoustic device is optimized to 
enable efficient and controllable separation of cells and viruses.  
Repeatable isolation of cell and virus species is demonstrated with both a 
well-characterized virus, Dengue Virus (DENV), and the novel Golden 
Gate Virus.  Next, a platform is built around this device to enable 
controllable, automated, continuous cell culture.  Beads are used to 
assess system performance and optimize operation.  Subsequently, the 
platform is used to culture both murine hybridoma (4G2) and human 
monocyte (THP-1) cell lines for over one month, and demonstrate the 
ability to manipulate population dynamics.  Finally, we use the platform 
to establish a multispecies culture with THP-1 cells and Sindbis Virus 
(SINV).  This work integrates distinct engineering feats to create a 
platform capable of enhancing existing cell virus studies and opening the 
door to a variety of high-impact investigations.     
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Chapter 1 INTRODUCTION 
1.1 Problem Statement   
Emerging and re-emerging diseases continues to be a significant 
threat to public health across all populations.  Rapidly changing 
environments due to climate change and urbanization, and expanded 
global and local travel, increases opportunities for emerging diseases to 
develop and progress into outbreaks.  RNA viruses are a particular threat 
due to their high mutation rate, leading to rapid adaptation, and account 
for up to one third of all emerging and re-emerging infections [4].  
Molecular tools are being rapidly developed and disseminated that allow 
unprecedented interrogation and monitoring of viral sequences over time.  
However, many questions still remain unanswered about the 
fundamental mechanisms of viral adaptation.  While examining clinical 
samples and in vivo studies will nearly always be a better model for 
human infection compared to in vitro systems, there are significant 
limitations.  Clinical data from current, or prior outbreaks undoubtedly 
provides the most relevant and applicable information, however, ethical 
and logistical constraints mean that investigators will always be chasing 
the infections, and learning in hindsight.  In vivo animal models provide 
a valuable platform to conduct controlled experiments, yet they can still 
be overwhelmingly complex, inexact and expensive.  On the other hand, 
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the accessibility, flexibility, control and cost effectiveness of simple cell 
culture make it a mainstay of many laboratories.  While these systems 
are far removed from in vivo conditions, they have been successfully used 
to probe virus evolution and adaptation [5,6].  However, traditional flask 
based systems are static and serial in nature, introducing artificial 
“passages” on cell and virus populations, which may not be 
representative of conditions viruses experience in vivo.  Thus, bridging 
technologies to address the unrealistic dynamics in static flask-based 
cultures, and the complexity and expense of in vivo experiments are 
desperately needed.   
Microfluidics has proved to be valuable resource to study, 
manipulate and create cell systems that more closely mimic in vivo 
conditions.  Applications span the landscape from tools to diagnosing 
different conditions [7], mimicking micro-physiological structure [8], 
genetically modifying microbes for new functions [9], to enabling 
screening of large pharmaceutical data sets [10].  Microfluidics is 
exceptionally qualified to manipulate biological specimen, as the small 
length scales allow unique physical methods to be used with cell 
populations.  Using physical techniques to manipulate cells has the 
advantage over molecular methods in that they can be applied without 
labeling and with minimal disruption to cells in their native state.  
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Acoustofluidic devices take advantage of small channel dimensions to 
establish standing waves that impart radiation forces on suspended 
particles.  Cells can be isolated in distinct positions, based on size, 
density and compressibility, allowing for separation and purification.  
While these devices tend to be fairly robust, cell focusing position is 
traditionally constrained to pre-determined positions in the channel. 
While there are many examples of success in using microfluidics, 
numerous technologies are hindered by inconsistent device operation 
and limited throughput.  While often seen as an advantage, the limited 
volume requirement of microfluidic devices often results in low-
throughput.  To increase the acceptance and utility of microfluidic 
devices it is desired to be able to use them both for processing small 
sensitive samples, as well as large volumes.  An additional challenge is 
device dependability.  Due to the small dimensions microfluidics are 
prone to clogging and fouling.   
In this thesis we address the challenge of developing a system to 
enable automated cell culture, for the ultimate goal of using it to 
establish a steady state cell-virus system.  First, we develop a device to 
reliably isolate cells and viruses in a non-invasive label–free manner 
using acoustic forces.  Next, we address two challenges with 
implementing microfluidics for large volumes: Increasing throughput, 
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and achieving robust device operation for extended periods.  Finally, we 
use these tools to develop a continuous perfusion platform that more 
closely replicates in vivo dynamics while achieving greater experimental 
control and flexibility than standard cell culture techniques.   
1.2 HYPOTHESIS AND AIMS  
The overarching mentality that has inspired this work is: The 
inherent heterogeneity in a system defines the bulk properties.  Only by 
examining and understanding individual units it is possible to design a 
controllable system that produces clear and valuable information.  The 
central hypothesis of this thesis is that by using microscale techniques it 
is possible to more carefully and precisely examine and control biological 
systems compared to bulk methods.  The overall goal of this work is to 
develop minimally invasive tools to study and manipulate biological 
systems.  These tools are integrated to create a system that capable of 
monitoring and directing cell and virus growth and interactions.  We 
hypothesize that we can use a microfluidic acoustophoretic separation 
device to establish a continuously-perfused viral infected culture and 
alter virus dynamics.  To investigate virus dynamics, we compare viral 
growth rates in our perfusion system compared to static flasks.  We 
further speculate that that growing virus in a dynamic system will select 
for different viral species in comparison to traditional static culture flask 
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and look for changes in the virus consensus sequence after being grown 
in our culture system.       
SPECIFIC AIM 1: CHARACTERIZE AND OPTIMIZE AN ACOUSTIC 
SEPARATION PLATFORM TO MOVE CELLS FROM A SAMPLE STREAM TO A CLEAN 
BUFFER STREAM.   While numerous devices exist to achieve size 
separation, we believe our technique surpasses existing devices in key 
categories that make it better for incorporation into a platform for 
multispecies cell culture.  We use acoustic forces to manipulate cells, 
which is an active technique that allows separation to be tuned without 
altering the system set up.  Our design improves upon existing 
acoustofluidic devices, by using a “transparent” wall to subdivide the 
channel.  This design improves device stability, and allows us to achieve 
higher flow rates than existing devices.  We determine that acoustic 
waves can be transmitted through silicon walls, contrary to traditional 
assumptions.  Additionally using our unique microfluidic design we 
investigate the physics behind sound propagation, and discovered that 
by using different materials we can alter the node position in a 
predictable manner based on the speed of sound in each material.     
SPECIFIC AIM 2: DEVELOP A ROBUST PLATFORM TO ACHIEVE 
CONTINUOUS OPERATION OF A MICROFLUIDIC DEVICE, WITH AUTOMATED 
MONITORING AND ENHANCED CONTROL OVER SYSTEM INPUTS AND OUTPUTS.   
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While perfusion culture systems are commercially available, complete 
systems often lack flexibility and are traditionally geared towards 
industrial applications rather than research.  Therefore, this aim seeks to 
generate a mesoscale device capable of surpassing existing perfusion 
systems in flexibility and control.  The device developed in Aim 1 is 
incorporated into this system to separate large and small species, in a 
tunable manner, giving us added control over the system.  This aim not 
only addresses the immediate goal of achieving a continuous, automated, 
perfusion system, but also tackles the broader challenge of adapting 
microscale devices for larger scale operations.   
SPECIFIC AIM 3: USE THE PLATFORM DEVELOPED IN AIM 2 TO 
MANIPULATE CELL CULTURES AND VIRAL POPULATION DYNAMICS.  As a 
demonstration of platform reliability and the ability to minimize un-
physiological disruptions to culture environment, the system is used to 
culture multiple cell types for over one month.  Using the acoustic device, 
the cells are continuously washed of waste products, re-suspended in 
clean media and returned to the culture system.  With the media being 
continuously renewed, the cells can attain higher cell densities and 
growth rates compared to flask based systems.  By adjusting operating 
parameters, cell growth is manipulated.  We demonstrate controllable 
removal of virus from the system, as well as monitoring viral growth rate.  
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To investigate the effect of slowly removing free virus from the system we 
examine changes in the consensus sequence of the variable receptor 
binding region of the Sindbis virus after being cultured in our platform.   
1.3 STRUCTURE OF THESIS 
First, we review existing flow-though, label-free microfluidic 
separation technologies (Chapter 2).  Next, the benefits and challenges of 
applying these techniques to different applications are discussed 
(Chapter 3).  Finally, we outline existing cell culture systems and how a 
mesoscale continuously perfused culture platform can make an impact 
in viral evolution studies (Chapter 4).  In Chapter 5 we detail our 
acoustofluidic device development and optimization, and in Chapter 6 we 
investigate different modes of operation and the ability to achieve high-
throughput separation.  Chapter 7 describes our generalizable 
automation platform to perform sensitive separations of precious 
samples, and in Chapter 8 we build upon this platform to achieve long-
time operation for large volume applications.  Lastly, in Chapter 9 we use 
this platform to perform automated cell culture, manipulate cell growth 
kinetics, and demonstrate a viral infected culture.  To conclude, we 
review the contributions this work makes to acoustofluidic design, 
improving microfluidic device operation for both small and large volume 
applications, and in developing a bridging technology for cell culture, 
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specifically aimed at probing virus dynamics and evolution.  We further 
discuss future directions for this work and impactful applications. 
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Chapter 2 REVIEW OF MICROFLUIDIC SEPARATION TECHNOLOGIES 
Sample separation and fractionation is one of the most promising 
areas of application for microfluidic technologies.  A myriad microfluidic 
separation strategies have been demonstrated for fluid-suspended 
particulates and colloids, as well as for chemical and biological species; 
several reviews provide overviews of recent progress and developments in 
these fields [11–18].  Our goal is to use microscale technologies to 
manipulate and study cellular systems.  Therefore we focus on using 
techniques that are minimally invasive and developing methods to help 
recapitulate conditions more similar to the in vivo environment.  The 
small dimensions of microfluidic devices allow novel physics to be 
explored.  Many different modes have been used to achieve separation of 
different species; we focus on methods that can be performed using 
native sample properties (i.e. label-free).  As our goal is to use micro-
scale methods to manipulate cell-virus populations we pay particular 
attention to higher-throughput techniques.  Here, we review a few key 
techniques (summarized in Table 2-1) which highlight the diversity and 
applicability of using microscale techniques for particle manipulation, 
with a particular focus on continuous flow methods. 
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GENERAL OPERATION SPACE FOR MICROFLUIDICS 
The majority of microfluidic devices operate under laminar flow.  In 
this case, the movement of particles through the device should follow 
deterministic flow lines without external input.  Laminar flow conditions 








Where ρ is the fluid density, 𝒗  is the fluid velocity, L is the 
characteristic length, and 𝜇  is the fluid viscosity.  Unlike macroscale 
devices, microdevices operate in the laminar flow regime with nearly all 
fluids due the small length scales (generally less than 1mm).  Since the 
flow is well defined under laminar flow, it is possible to utilize different 
force fields and phenomena to manipulate particles and move them from 
their original streamlines, enabling sample fractionation.   
2.1 HYDRODYNAMIC AND FILTRATION 
This class of device takes particular advantage of the laminar flow 
profiles in microfluidic devices.  Devices are designed to harness inherent 
fluid flow forces and innovative designs manipulate the flow fields to 
separate different particles.  The majority of these devices use size-
exclusion effects to separate particles by size, shape and deformability 
[19–22]. 
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2.1.1 SIZE EXCLUSION 
Pillar type devices bump particles to different stream lines and 
have been used with astounding resolution and precision.  These devices, 
known as deterministic lateral displacement (DLD) arrays exploit the 
splitting of laminar flows due to obstacle arrays that alter large particles’ 
trajectory, while allowing particles smaller than the critical diameter to 
flow straight through [23]. This technique has been applied to a wide 
range of specimen; from high-throughput separation of cancer cells from 
blood [24,25], to purification of nucleic acids with expertly fabricated 
devices [26], to fieldable tests for parasites [27].  Some inherent 
challenges for this method are clogging due to the large arrays of posts 
which are directly in line with the flow, and device fabrication as the 
feature size must be on the same order as the particle size.   
Crossflow filtration devices help address some of the challenges 
with physical filtration such as clogging and device lifetime by allowing 
particles to be filtered out perpendicular to the direction of fluid flow.  
Crossflow filtration has been used to concentrate algae [28], fractionate 
blood [29,30], and isolate hematopoietic stem cells [31].  Choi et al. use 
slanted objects to create secondary flow and sort particles by size [32] 
and have built on this technique to isolate and wash cells [33].  To 
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reduce clogging pulsatile flow is often used in these cases [29–31], 
making it more difficult to integrate into continuous flow processes.   
2.1.2 FLOW FRACTIONATION 
Flow fractionation techniques further assuage concerns about 
clogging as they do not require physical obstructions, rather relying on 
flow pinching and fluidic resistances to manipulate particles.  In pinched 
flow fractionation [34] sample flow is pinched to the wall by a higher 
secondary sheath flow, causing the particles to be aligned to the wall.  
The flow is then allowed to expand into a wide region and the differences 
in particle position due to particle size will be amplified as the flow profile 
broadens, allowing particles to be separated perpendicular to the flow 
direction.  By optimizing output fluid resistance asymmetric pinched flow 
fractionation was born, and used to isolate red blood cells from blood 
[35].  Hydrodynamic filtration [36] also takes advantage of flow splitting, 
but instead using fluidic resistances to fractionate particles of different 
size.  Using this method different types of liver cells were sorted at up to 
50 µl/minute [37].   
2.1.3 INERTIAL AND FLOW MANIPULATION 
The phenomena of particles focusing to defined positions in a fluid 
channel was observed in the 1960s [38], however, it wasn’t until the field 
of microfluidics had grown that researchers rediscovered inertial focusing 
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and applied it to cellular systems [39].  Inertial devices are rather non-
traditional in the realm of microfluidics, as they operate in regimes just 
beyond stokes flow.  Under these conditions both fluid viscosity and 
inertia are important in determining how the fluid behaves.  Unlike the 
methods discussed above, inertial devices do not use size-exclusion 
effects in the usual manner.  In these devices, the particle dimensions 
are on the same order as the channel dimensions, the object experiences 
a range of shear forces due to the parabolic flow profile, resulting in 
inertial lift forces.  These forces are balanced by wall repulsion forces 
generated from an asymmetric wake at the channel walls, resulting in 
stable equilibrium points [39–42].  Other phenomena that occurs within 
these types of devices is secondary flow generated due to curving 
channels or obstacles which can be used to increase the speed of particle 
migration to equilibrium points [43], as well as generate new equilibrium 
positions [44–46].  The bulk of these devices rely on different rates of 
particle migration to equilibrium points [42,47], or size cut offs to isolate 
cells of interest [48].  Generally, these devices are designed to operate at 
moderate Reynolds numbers, ~15–200, while remaining safely out of 
turbulent flow conditions.   
These techniques have been successfully implemented for a variety 
of high-throughput separation applications.  For example, spiral 
 14 
channels have been used to isolate circulating tumor cells from clinical 
samples [49].  Other devices combine multiple methods on a single chip 
to enhance selectivity; Shen et al. use inertial focusing and separation 
combined with crossflow filtration to isolate rare cells from blood [50]. 
2.2 DIELECTROPHORESIS 
Dielectrophoretic forces manipulate particles in an inhomogeneous 
electric field based on the polarizability of the particle with respect to the 
medium.  When neutral particles are exposed to a high frequency 
alternating current electric field, they become polarized and dipoles are 
formed.  When the field is inhomogeneous, a net force is generated:  
〈𝐹𝑑𝑒𝑝〉 = 𝜋𝜀𝑚𝑟
3𝑅𝑒[𝑲(𝜔)] ∙ ∇|𝑬|2 









Where 𝑟  is the particle radius, 𝑬  is the electric field 𝜀  is the 
permittivity, 𝜎  is the conductivity, and 𝜔  is the frequency.  The 
subscripts 𝑚 , and 𝑝  represent the medium and particle complex 
permittivity respectively.  𝑲(𝜔) is the Clausius-Mossotti (CM) factor, and 
defines how a particle will act in a given system.  𝑲(𝜔)  varies 
between -0.5 to 1.  When it is negative particles move away from the 
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region of high electric field gradient (negative DEP, nDEP), and when it is 
positive the opposite occurs (positive DEP, pDEP).  Physiological 
solutions have high conductivities on the order of S/m.  In physiological 
solutions biological cells generally experience negative DEP across all 
frequencies.  However, in low conductivity solutions (mS-μS/m) changing 
the frequency of the applied electric field it is possible to change from 
nDEP to pDep and vice versa.  The frequency at which the CM factor is 0 
is defined as the cross over frequency.   
Dielectrophoretic separation presents a unique opportunity to 
isolate cells with specific electric properties by exploiting differences in 
crossover frequencies.  Using this technique circulating tumor cells were 
isolated from white blood cells [51]. Similarly, differences in electric 
properties between breast and colorectal cancer cells [52] and 
differentiated and undifferentiated stem cell lines [53] enable separation 
of different species.  
Although the DEP force scales with particle volume, the force 
decays rapidly away from the electrode edges since it scales with the 
gradient of the electric field squared.  In this manner, it is possible to use 
a dielectrophoretic field in combination with the gravitational field to 
isolate cells based on density differences [54].  Using particles of the 
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same density this design was adapted to fractionate multiple sized beads 
[55].   
However, in the case where particle density is unknown or varied, 
generating a uniform electric field gradient across the height of the 
channel can simplify device operation.  Thus, multiple devices use three 
dimensional electrodes rather than electrodes that are patterned on a 
single plane [56,57].  When the DEP field is uniform across the channel 
height particles can be separated by size.  This technique was used to 
separate platelets from blood cells [58]. Wang et al. develop an elegant 
design where two sets of DEP interdigitated electrodes create two 
opposing fields, thus different cell types can be focused to different 
positions based on their dielectrophoretic properties [59].  In this design 
the frequencies and power for each field can be adjusted during run 
time, allowing the device to be tuned for specific applications.   
2.3 ACOUSTOPHORESIS 
Acoustophoresis is well established as a method to manipulate 
biological species, and is attractive for cell separation for multiple 
reasons.  Firstly, applying acoustic forces to cells has been shown to be 
minimally invasive and does not affect cell expression or viability [60–62].  
Secondly, acoustic separation is generally compatible with physiological 
solutions, and specimen usually do not need to be re-suspended in 
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different buffers; assuming the fluid is amendable to flowing though the 
fluidic device.  Acoustic devices tend to be very robust, and have been 
used in large scale applications for cell harvesting and concentration 
[63].   
2.3.1 PHYSICS 
The fundamental mechanism of using ultrasound to move 
microparticles across fluid streamlines was first demonstrated nearly 20 
years ago by Feke and coworkers [64,65] and extended by Coakley et al. 
[66,67]. 
Starting with the governing equations for fluid dynamics: 
Conservation of mass, momentum and energy, then applying 
perturbation theory the force generated on particles in an acoustic field 
can be derived [68].  The primary force can be described as:  









Equation 2-1 Acoustic Primary Radiation Force 
Where φ is the contrast factor, p0 is the pressure amplitude, Vp is 
the particle volume, β is the compressibility, k is the wave number, ρ is 
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the density, λ is the wavelength, and x is the distance from the pressure 
node.  Subscripts p and m stand for the particle and the medium 
respectively.  The primary force acts to focus particles to either the 
pressure nodes or anti nodes depending on the sign of the contrast 
factor.  Solid particles like cells are generally focused towards pressure 
nodes while particles like lipids are focused to pressure antinodes in 
water or physiological solutions.  Since the acoustic force scales with 
particle volume [69], size based separation is the most common 
application in microfluidic devices.  Among the various separation 
approaches available in microfluidic systems, acoustophoresis competes 
only with inertial focusing [44] for being the highest-throughput 
microfluidic size separation technique [70] . 
2.3.2 BULK ACOUSTIC WAVE RESONATORS 
Due to the simplicity of device design, fabrication and operation, 
Lund type [71] acoustic microfluidic devices are popular for particle 
manipulation.  Channels are fabricated in materials that enable acoustic 
waves to be transmitted with little losses.  Acoustic resonance is 
established orthogonal to the piezo transducer’s actuation axis [72], 
which makes it easy to observe focusing through the device’s glass lid, 
and devices can be produced with high precision by means of standard 
microfabrication techniques [73]. Typically, the channel width and the 
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acoustic actuation frequency are matched to create a half-wave 
resonance within the device, to create a single node at the channel 
centerline and two antinodes at the channel walls.  However, this design 
is fundamentally limited for particle separation and concentration.  For 
optimal concentration, a trifurcation is required at the outlet [71,74,75] 
which adds complexity and may alter the laminar profile reducing 
separation efficiency.  Multi-mode superposition [76] has proposed as a 
solution to this limitation, however, this technique requires careful 
temporal manipulation to switch between different modes of half and 
quarter wavelength operation. 
2.3.3 MATCHED LAYERS 
Another class of devices, makes use of precisely matched material 
layers to generate quarter-wave resonance within the fluid channel and 
drive particles toward a pressure node at or near a channel wall [77–80].  
While this is advantageous for surface-binding assays, it is undesirable 
in situations where the aim is to efficiently extract or separate particles 
in a high throughput fashion, since streamlines near the wall are slower-
moving, and particles are more likely to adsorb to the surface.  
2.3.4 TRAVELING WAVE ACOUSTIC RESONATORS 
In contrast, a different flavor of acoustophoresis uses traveling 
acoustic waves to generate interference patterns generating different 
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pressure nodes and anti-nodes depending on channel orientation and 
frequency.  Arbitrary node positioning within the microchannel has 
previously been demonstrated [81] using phase [82,83] and frequency 
[84] control with surface acoustic waves.  By adjusting the incident angle 
of the acoustic wave with respect to the channel particles of different 
sizes can be separated [85].  However, the majority of these devices use 
channels fabricated from polydimethylsiloxane (PDMS), which dissipates 
acoustic energy, limiting the effectiveness of focusing.  In all cases such 
devices have been limited to ~10 µL/min maximum flow.  Additionally, 
absorption and leaching of chemicals and gas permeability in PDMS 
presents challenges for certain applications.   
2.3.5 CURRENT TECHNOLOGY 
ACOUSTOFLUIDIC DEVICES 
Ultrasound pressure fields have been used for a wealth of 
applications such as fluid pumping [86], mixing [87], immunoassays [88], 
drug delivery [89], and single-particle positioning [90], to name only a 
few.  By far the most widespread applications have been in separating 
and sorting biological and non-biological particles, using both bulk 
[91,92] and surface acoustic waves [93–95]. Generally, acoustic 
separation devices rely on either migration velocities of different sized 
particles or on differences in contrast factors.  Using differences in 
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contrast factors to separate particles is attractive since this process is 
definitive and not as time sensitive.  However, the majority of biologically 
relevant particles, such as cells, have similar contrast factors.  While this 
technique has been used successfully to separate lipids from blood [92], 
it is often difficult to separate biological particles without using specific 
buffers.  Petersson et al. adjust the fluid density to separate platelets and 
red blood cells with 92% of red blood cells exiting in one outlet and 99% 
of platelets exiting in another outlet [96]. Improvements to this design 
include pre-focusing in both the horizontal and vertical direction.  First 
all species are focused in two dimensions to the channel edges and 
midline.  The sample then enters the next region where another 
transducer induces a node at the center of the channel.  This design 
requires two focusing regions and thus two transducers excited at 
different frequencies.  Using this design, white blood cells spiked with 
circulating tumor cells, were separated with 79–99% efficiency [97].  
Existing work also suggests that acoustic separation can be used to 
distinguish viable and non-viable cells, as cells that have undergone 
apoptosis have different acoustic properties and are smaller [98]. 
Despite the success of Lund type acoustophoretic separation 
devices [71], the inflexible placement of the acoustic node with respect to 
the channel makes this technique non-ideal for separation applications.  
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Generally half wavelength devices are employed that focus particles 
either to the channel walls or channel center.  When particles are 
focused to the channel walls, adsorption of species may reduce sample 
recovery for concentration applications [78].  When particles are focused 
in the channel center a trifurcation is required at the outlet for optimal 
concentration, increasing device complexity [96,97]. 
CELL-VIRUS SEPARATION 
Despite the popularity of acoustophoresis for size based separation 
it is seldom applied to cell-virus mixtures.  However, a number of devices 
move cells across fluid interfaces [42,67].  Theoretically, these devices 
should be able to separate cells and viruses as viruses should remain in 
the original solution due to the drastic size difference.  Most microfluidic 
devices that address virus isolation are interested in pathogen detection 
and extract viral nucleic acid from samples after lysing cells and other 
constituents, rather than extracting live viruses and cells [99].  Devices 
that have been used to separate viable cells and viruses do not achieve 
high separation efficiency or throughputs.  Zhao et al. layer blood over a 
buffer stream and use cell sedimentation to isolate cells from spiked 
viruses [100].  This method is inherently slow since separation depends 
on residence time.  The device was operated at 6µL/min [100].  
Colleagues at Lawrence Livermore National Laboratory (LLNL) previously 
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designed an acoustic cell-virus separation device; however, complete 
separation was not possible.  A cell-virus sample and buffer solution 
were injected in parallel using a H-filter design, and was acoustically 
excited such that cells focused to the center of the channel, while viruses 
remained in the lower half [101].  Since the cells did not cross the fluid 
interface between the sample input and the buffer stream, cells could 
only be enriched from viruses, not separated.  Generally cell and virus 
separation is achieved via centrifugation [102].  While well established, 
this method is a fairly time intensive benchtop technique.  In addition, 
centrifugation has been shown to increase infectivity for certain viruses, 
and may change cell-virus interaction dynamics [103,104].  While 
centrifugation is useful to accelerate diagnosis [102], it may confound 
experiments trying to study cell-virus interactions.  Therefore an 
alternative method to extract viable cell and viruses from samples is 
desired. 
Drawing upon concepts that have been previously demonstrated, 
including the H-filter [105], asymmetric node position [76], and 
acoustically transparent membranes [106], a unique acoustic focusing 
technique to enable high efficiency extraction of cells is presented in 
Chapters 5 and 6.  We hypothesize that subdividing the channel permits 
the pressure node to be positioned arbitrarily.  Additional, we expect that 
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using different materials will allow us to predictably adjust the acoustic 
pressure node location.  Arbitrary node placement can reduce the 
complexity of device fluidics, reduce species absorbed to the wall, and 
enable more efficient particle separation. 
2.4 SUMMARY AND CONCLUSIONS 
While numerous techniques exist to fractionate samples, the 
presented examples serve to highlight the potential of microfluidic 
technologies to isolate particles using unique and exotic inherent 
physical cell properties.  By operating at the microscale, these methods 
have the potential to probe individual cells, and identify specific subsets 
of the population.  The platform presented in Chapter 7 and Chapter 8 
seeks to make these technologies more accessible by developing a 
generalizable control system to enhance device operation of flow-through 





Table 2-1 Overview of continuous flow label-free microfluidic 
separation technologies.  
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Chapter 3 STRENGTHS AND CHALLENGES FOR MICROFLUIDICS 
In the previous chapter we highlight the appeal of microfluidic 
separation technologies, for label-free, continuous particle fractionation.  
While microfluidic devices are intrinsically well suited for small volume 
separations, these qualities make them attractive for large scale 
processes as well.  In this chapter, a dialogue is opened to the benefits 
and challenges of using microscale techniques for small and large scale 
operations, and different approaches to realize high throughput and 
robust device operation are presented. 
3.1 SMALL VOLUME APPLICATIONS 
Microfluidic devices enable precision processing of minute samples 
challenged by few other techniques.  Multiple techniques discussed in 
the previous chapter can separate cells based on density differences, in a 
flow through manner allowing small volumes of samples to be processed.  
In contrast, bulk techniques use density gradients and centrifugation to 
isolate particles of different sizes.  The standard working volumes are on 
the order of 1-10mls, although specialized tubes are available to fraction 
blood samples as small as 0.5ml [107].   
One of the main attractions of microfluidics is the small 
dimensions and thus reduced volumes requirements for reagents, and 
enhanced control over local conditions.  The high surface area to volume 
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ratio also increases the heat dissipation which has resulted in higher 
efficiency electrophoresis [108] and chemical synthesis [109].  In 
analyzing biomolecules, reducing reagents minimizes costs, and can 
improve the sensitivity of detection techniques by confining generated 
products to a small volume [110].  This can be extremely important when 
trying to identify small compounds for drug discovery [111], or study 
single cells [112].   
For these reasons, microfluidic devices are ideal for processing rare 
samples with limited quantities.  However, momentary clogging or 
inconsistencies in flow can be extremely detrimental to separation 
efficiency and may have dire consequences when being used for clinical 
specimen.   
3.2 LARGE VOLUME APPLICATIONS 
On the other hand, when considering devices whose purpose is to 
process samples, the low volume feature becomes a double edged sword.  
A consequence of small sample volumes is that it becomes increasingly 
more likely to miss events of interest due to Poisson statistics.  When 
only a small portion is analyzed it is possible to obtain a false negative 
simply because the portion of your sample did not contain the analyte of 
interest.  While this is especially relevant for diagnostic bioassays these 
implications affect basic biology applications as well.  For example, when 
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studying virus evolution small sample sizes result in smaller populations 
of virus, which may not capture the viral mutant diversity present in vivo 
[113].  While a major benefit of microdevices is the ability to observe and 
obtain data on the individual cell level, it also presents a challenge of 
generating enough data to understand what is happening on a 
population level.   
Working in the microscale regime makes unique physical 
phenomena accessible as discussed in Chapter 2.  These techniques 
often surpass bulk techniques in sensitivity and specificity; however 
usually they cannot be scaled up.  For example, multiple microfluidic 
acoustic devices can sort particles by size, and specific size cut offs can 
be established when processing samples.  In contrast, commercially 
available large-scale acoustic separation devices (Amplikon, BioSep) 
utilize a slightly different physical phenomenon and are traditionally 
used to collect all cells, regardless of the size.   Therefore, an interesting 
challenge and opportunity for the field of microfluidics is being able to 
take devices that are inherently in the “micro” world and use them for 
macroscale applications.  One approach to bridging the gap between 
microfluidics and macro or mesoscale volumes is to increase device 
throughput.  In this section, we review microfluidic devices and employed 
methods that enable high-throughput separation. 
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THROUGHPUT OF TECHNOLOGIES REVIEWED IN CHAPTER 2 
The sample throughput to be considered “high-throughput” varies 
by mode of separation.  For hydrodynamic separation, which employs 
manipulating fluid streams with sheath flows and fluidic resistances, 
flow rates tend to be much lower than other methods [18].  One of the 
highest throughput devices in this class of techniques separates liver 
cells at 50 µl/min [114].  Similarly, dielectrophoretic separation 
techniques tend to operate below 100 µl/min due to the low force away 
from electrode edges, and the limited ability to increase the voltage due 
to joule heating and electrolysis [115]. 
Although acoustic devices operate in a similar manner, using a 
secondary active field to alter particle trajectories, much higher 
throughputs can be reached.  Devices commonly operate in the 100 
µl/min range, especially for bulk acoustic resonators.  Adams et al. 
achieve incredible flow rates by employing large channel dimensions in a 
matched layer acoustic resonator.  They isolate red blood cells from 
whole blood at up to 16 ml/min [70].  However, to achieve this 
throughput, channel dimensions of 60x170x0.83mm are required. 
An elegant solution to low throughput microfluidic devices is to 
take advantage of the inertia generated by high flow rates to achieve 
separation, as inertial microfluidic devices do.  These devices regularly 
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process samples on the order of ~1-5ml/minute [48,116,117].  These 
devices have been used to isolate white blood cells from diluted whole 
blood [118],  and circulating cancer cells from clinical samples [49].  
Since these techniques rely on the high flow to generate forces, they are 
incapable of operating at lower flow rates, and have restricted ability to 
tune separation in situ, limiting the versatility of these devices. 
OPTIMIZE SPECIFIC DEVICE PERFORMANCE 
Optimizing individual device performance can increase throughput 
by orders of magnitude.  Li et al. optimize device parameters in their 
tilted angle standing wave acoustic separator to improve the throughput 
by 20Xs and achieve 20 µl/min flow rates when isolating CTCs from 
clinical breast cancer samples [85].  Loutherback et al. introduced a 
significant design modification to traditional DLD arrays by using 
triangular posts instead of the traditional circular posts [24].   Using this 
technique, they were able to achieve flow rates of up to 10 ml/minute to 
separate circulating cancer cells from diluted blood; thus increasing the 
operating flow rate by orders of magnitude over traditional DLD arrays 
[24].  By increasing the filtration area Schirhagl et al. increased the 
throughput of their crossflow filtration device by 4Xs to isolate 
hematopoietic stem cells from a marrow sample at 17.2 µl/min [31].  
Since inertial and hydrodynamic devices are passive separation 
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techniques the parameter space for optimization is somewhat limited 
without redesigning devices.  Tuning the flow rate or flow profile can 
improve separation efficiency or even alter the mode of separation in 
these devices [44,119], but complicates device operation as the 
separation becomes coupled to the throughput.   
Devices that use active separation techniques such as 
acoustophoresis or DEP can improve separation efficiency by increasing 
strength of the force field, without requiring further device development.  
This can be achieved simply by increasing the power supplied to the 
piezoelectric element or electrodes, respectively.  By improving device 
design further gains in throughput can be realized.   By creating an 
acoustofluidic device capable of asymmetric node positioning, we 
successfully separate particles at 450 μl/min, while other similar devices 
operate in the range of 50-200 μl/min [1].  Due to the asymmetric node 
positioning, we are able to achieve extremely efficient particle migration 
due to the acoustic field, resulting in high separation efficiency. 
SYSTEM LEVEL APPROACHES: PARALLELIZATION AND LONG-TIME OPERATION 
For passive separation techniques running multiple devices in 
parallel, or including parallel designs on a single chip provide a simple 
way to quickly increase throughput without further optimization.  256 
parallel inertial channels were used to order cells [120], and 8 parallel 
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channels were used to isolate CTCs from blood [48].  Combining inputs 
and outputs on parallel devices further simplifies device design and 
operation; however device stability may be reduced as multiple fluidic 
pathways can make it difficult to clear obstructions.  Inglis et al. use 6 
parallel DLD arrays, and frequently observe blockages which negatively 
impact device performance [121].  For techniques that require active 
fields, parallelizing devices is often much more difficult.  For example, to 
run multiple acoustophoretic devices in parallel it would likely be 
necessary to incorporate additional function generators and power 
amplifiers to excite the PZTs at the appropriate frequency.  In theory 
devices with the same design should have the same resonant frequency; 
however, in our experience we find each device must be calibrated for 
optimal results.  Improvements in device design and fabrication may help 
address this requirement. 
Increasing the amount of time a device can be used allows larger 
samples to be processed.  However, successful long time and high 
volume operation usually requires large channel dimensions, or well-
conditioned samples that have been pre-filtered to minimize the risk of 
clogging.  Chung et al. demonstrate continuous inertial focusing for up to 
8 hours with a bead solution[122]. 
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3.3 MAKING MICROFLUIDICS ROBUST 
SIMPLE DEVICES: LATERAL FLOW 
Devices that utilize robust physical phenomena span industrial, 
research and even consumer fields, as they are easy to operate and 
reliable.  Lateral flow assays have been a mainstay of Point-of-Care (POC) 
diagnostics [7].  While the ubiquitous pregnancy test is a starting point, 
these assays are rapidly being taken to the next level, especially with the 
growth of paper microfluidics [123,124].  While these types of assays 
have definitively been some of the most readily adopted and impactful in 
the short term, restricting ourselves to what is “easy” overlooks powerful 
techniques that can be more difficult to implement.  More complex 
devices generate different fields and forces to process and analyze 
samples.  For example, dielectrophoretic and acoustophoretic separation 
techniques are less adaptable to low resource settings, as they usually 
require strong electric fields with frequency control.  While efforts have 
been made to adapt various techniques to low resource applications 
[27,125] in many cases, success is often dependent on infrastructure 
surrounding the operation of the device to ensure robust operation and 
that no sample is wasted or lost.   
COMPLETE SYSTEMS INTEGRATION 
In recent years, many of these technologies have been brought to 
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market and are making significant impacts in various fields; from 
isolating rare cells, to POC diagnostics, to integrated systems that 
perform assays in record times with tiny volumes.  Some of the most 
successful devices are ones which incorporate all sample processing 
steps on chip, and thereby remove human error associated with manual 
processes [126–128].   
A well acknowledged, but still prevalent problem in research is that 
negative results go unreported.  Similarly, optimization and failed 
experiments are often overlooked, and only the final product is 
presented.  While this is an inherent part of research, the challenges 
associated with getting a particular device to run robustly and 
consistently are not apparent to those without intimate experience with 
devices.  The challenge of developing completely integrated systems can 
be deduced from the number of studies which perform many of the 
complex analysis and detection techniques on chip, but still require a 
significant front-end effort to pre-process samples.  For example, Siese et 
al. propose a chip-based system for on-site disease diagnosis, but sample 
nucleic acid must be extracted prior to introduction into the chip [129].  
Roy et al. develop an impressive platform capable of lysing bacterial 
spores, purifying nucleic acid, performing PCR and detecting specific 
sequences via hybridization [128].  However, they have tested their 
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platform using bacteria in distilled water, suggesting that for more 
complex samples pre-processing steps may be required.   
With complete integration untrained users can perform complex 
assays, but a significant effort must be dedicated to the development of 
each individual assay.  For example, iSTAT developed one of the most 
successful POC microfluidic based diagnostics, a blood chemistry 
analysis test.  They were founded in 1983, but their product only 
reached the market in 1992 [7]. Similarly, Cepheid, founded in 1996, 
deployed a standalone unit for tuberculosis diagnosis in low-resource 
settings in 2012 [7].  However, partnership with the Foundation for 
Innovative New Diagnostics (FIND) to develop this assay began in 2006 
[130].  Chin et al. review successful microfluidics diagnostics brought to 
market, and the funding obtained prior to the approval of the first 
product; Cepheid received $84.3M prior to launching their first product 
[7].  Furthermore, these platforms tend to be highly specialized for the 
specific assay.  Other modules using the same technique can be 
implemented readily [131], but using the platform for a completely 
different procedure requires more development. 
MODULAR APPROACHES 
While a complete lab-on-a-chip sample-in, answer-out platform 
has been touted as the “holy-grail” of microfluidics, this configuration 
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can be limiting, as each assay must be redesigned for each specific 
application.  For consumer fields it is of utmost importance to develop 
robust assays that require little training to run, however in research 
settings it is often preferred to keep processes independent, to allow more 
flexibility.  For example, by performing sample preparation off chip (or in 
specialized devices) samples can undergo different pre-treatments to 
make them amendable to downstream processing steps [132].  In this 
light, modular and interchangeable devices are preferred that can be 
adapted for specific tasks.  With an array of different companies and 
institutions capable of aiding interested parties in accomplishing their 
microfluidic goals [133], the question becomes, how can we integrate 
microfluidics into existing infrastructures?  
One approach is to develop technologies that can interface with 
existing systems, such as liquid handling robots.  Meyvantsson et al. 
develop a passive pumping scheme to culture cells which can be 
actuated using automated pipetting [134].  By designing chips with a 
standard footprint of a 96-well plate, Au et al. develop a culture device 
capable of using standard absorbance plate readers to measure cell 
growth [9]. 
Other devices take advantage of off-the shelf laboratory equipment 
and develop control platforms to automate experiments.  Sabounchi et al. 
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use active control with a programmable high voltage power supply to 
generate a DEP field to concentrate bacterial spores [135].  They then use 
impedance sensing to measure concentration.  Their system employs a 
microcontroller that interfaces with all equipment and collects data, 
which operators can control through a user menu.  Fidalgo et al. have 
developed an array of valves for fluidic handling and cell culturing with 
114 individual valves controlled by 15 pneumatic inputs [136].  They 
have developed software to program the valves, and use sequential 
scripts to generate complex behaviors.  Datta-Chaundhuri et al. develop 
a method to interface between standard CMOS chips and cultured cells 
[137].  By incorporating on chip amplifiers, high sensitivity, spatially-
resolved bio-sensing of cardiomyocyte beating was achieved. 
3.4 SUMMARY AND CONCLUSIONS 
Microfluidics techniques are inherently well suited to perform 
small volume separations, and can limit the amount of wasted sample.  
However, due to the small dimensions clogging is a common problem, 
which can result in complete loss of samples when the starting volume is 
limited.   
To use microfluidic devices for large volume applications, it is 
prudent to consider all the different approaches to improving device 
throughput.  Firstly, choose an inherently high-throughput separation 
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technique.  Of the techniques presented in Chapter 2, inertial 
microfluidic devices consistently operate at extremely high throughputs, 
with some acoustofluidic devices reaching similar throughputs.  In 
contrast, other dielectrophoretic and filtration separation techniques are 
generally regulated to flow rates of under 100 μl/min, with the exception 
of some DLD arrays.  Acoustic devices have the added flexibility of being 
an active separation technique which means separation efficiency can be 
modulated by simply controlling the supplied voltage.  Next, optimization 
techniques specific to the separation modality should be considered to 
further improve throughput.  Finally, generalizable techniques such as 
running multiple devices in parallel or implementing methods to allow 
devices to run for longer times can be deployed.   
Adoption of microfluidic technologies can be approached in 
multiple ways.  The most successful and widely adopted microfluidic 
technologies rely on simple, robust, physical phenomena, such as 
capillary action in lateral flow devices.  However, the real appeal of 
microfluidics is moving beyond simple colorimetric binary tests, and 
performing complex and novel assays.  To achieve general widespread 
use, complete integration of all steps in a contained sample-in answer-
out platform is desirable.  Yet, the development necessary to achieve that 
level of integration is unfeasible for many projects.  Furthermore, the 
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level of self-sufficiency of each device needs to match the target audience.  
For example, a diagnostic test to be deployed to a peripheral lab with 
intermittent or no power faces very different design criteria than a 
research tool that will be used by trained doctors and engineers in state-
of-the-art laboratories.  In the second case, it often makes more sense to 
focus on leveraging existing infrastructures, and designing modular 
devices that can be seamlessly integrated into established workflows.  
We present the system architecture created as part of aim 2 as one 
method to address these three challenges: 1. Achieving robust device 
operation for small sample volume, 2. Increasing device throughput to 
apply microfluidics to macro volumes, and 3. Integrating microfluidic 
devices with existing laboratory infrastructure. (Chapter 6 and Chapter 
7)   
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Chapter 4 REVIEW OF NON-TRADITIONAL AND LARGE SCALE CULTURE 
SYSTEMS 
This thesis focuses both on microscale cell-separation 
technologies, as well as integrating them with a larger scale culture 
system.  To give our work context, in this chapter we outline the different 
scales cell culture is performed at (Figure 4.1).  The platform presented 
in this thesis is developed with the goal of probing viral evolution; 
therefore in the final section of this chapter we outline basic virology 
concepts important for this work.  We hope this collection of studies 
delivers a convincing background as to why an integrated microfluidic 
culture platform can make an impact both at the basic science level, and 
for more applied biopharmaceutical applications. 
4.1 MICROFLUIDICS & CELL CULTURE 
4.1.1 RECAPITULATING NATURAL SYSTEMS: ORGAN-ON-A-CHIP 
There are many devices that seek to completely replace standard 
cell culture with microdevices engineered to create tunable environments 
that better mimic in vivo conditions.  For example, one of the main 
research thrusts at the Wyss Institute at Harvard is to generate 
functional organs-on-chip to compliment animal testing.  These systems 
tend to be on the μm to mm scale, and a large focus is in developing 
mechanical structures that replicate in vivo physiology.  Using micro-
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engineered systems, Huh et al. developed a “human breathing lung-on-a-
chip” which recapitulates the physiological stresses and strains 
experienced by lung epithelial cells [138].  Of particular interest is the 
opportunity to develop a “human-on-chip,” using these systems to 
induce stem cell differentiation from a single patient to generate different 
patient specific organ models for the epitome of personalized medicine.  A 
variety of different mock-organ systems have been developed to study the 
liver, kidney, gut, and heart to name a few [8].  As an in vitro method, 
real-time imaging, chemical and genetic analysis can be performed.  
While this technology promises to advance our basic understanding of 
both large scale organ system function, and specific molecular and 
genetic subtleties, they are a radical departure from traditional culture 
platforms and are not easily adapted to existing workflows.  Thus, they 
represent an important direction for basic research, and some smaller-
scale applications, such as personalized medicine and drug screening, 
but still face significant challenges to integrate with large, production 
scale, cell culture techniques [139].   
4.1.2 TINY VOLUMES, SENSITIVE MEASUREMENTS 
Small scale cell culture on chip has been used to precisely control 
the microenvironment and for sensitive cell monitoring.  Microfluidic 
chemostats have been used to culture bacteria, algae, yeast [9] and 
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adherent cells [140] over multiple days.  By incorporating fluidic 
handling, complex operations, such as genetic transformation, could be 
performed on chip [9].  Monitoring cell metabolism can be used as a 
measure of cell state, and has been used to determine if the anaerobic or 
aerobic pathways are active in droplet encapsulated yeast cells [141].  
However, in both these cases the environment changes as the cells 
proliferate, and the cell growth is varied throughout the experiment.  
First the cells show exponential growth, and then delayed or halted 
growth upon reaching a maximum density. 
Droplet microfluidics has had extreme success in culturing 
individual cells in their own “culture vessels”.  Unprecedented 
sensitivities are reached by encapsulating each cell in pL to nL volumes.  
In this manner, it is possible to contain cell byproducts in a small 
volume, thus increasing the limit of detection and adding single cell 
specificity. Wang et al. demonstrate screening large populations of yeast 
for high producing mutants for biofuel applications [110].  They couple 
droplet generation with a microfluidic enzymatic assay to measure the 
amount of desired product produced by each cell, and further sort the 
cells to enrich for desired traits.   
Continuous culture with constant perfusion of media allows 
steady-state conditions to be achieved, resulting in more constant 
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environment for cells.  On one hand, commercial perfusion and batch 
cell culture systems tend to be on the order of 100s of L [142], which is 
unrealistic for research scale studies.  Microfluidics makes small culture 
volumes accessible, but many devices are incompatible with downstream 
assays which still remain in the macro-world.  For example, Balagadde et 
al. demonstrate continuous bacteria culture and precise population 
observation, however with culture volumes of 16nL it is not possible to 
perform off line sampling.  Devices that operate in the pL-μL range rather 
than tens of milliliters range that is common in traditional cell culture, 
requires that subsequent analysis assays also be miniaturized. 
4.1.3 CONCLUSIONS 
Microscale platforms are invaluable for studying basic mechanisms 
and mimicking biological processes.  While some of the presented studies 
suggest potential to manipulate cell populations [110], many of these 
techniques are not easily scaled-up and serve more as research and 
screening tools, rather than starting points for production scale 
processes.   
4.2 MESO TO MACROSCALE CELL CULTURE SYSTEMS 
Industrial production of biopharmaceuticals is an important and 
growing field.  Large bioreactors are used to generate important and 
widely used biomolecules on the production scale.  Historically, these 
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systems tend to be batch suspension processes, but many companies are 
moving to perfusion cultures due to the increased output, reduced costs 
and improved product [143].  Commercial vessels can be as large as 
1000-2000 liters [143].  Even for smaller vessels the expense associated 
with each run is substantial; therefore optimization and development of 
specific processes must be done at a much smaller scale.  In this section 
we review different applications for bioreactors, and transitional systems 
that make large scale biopharmaceutical production possible. 
4.2.1 APPLICATIONS 
HARVESTING BIOMOLECULES 
The first breakthrough for cell culture in the realm of 
biopharmaceutical production was in the 1970s and 80s with the 
creation of hybridoma cells.  Hybridoma cells are generated by fusing a 
specifically selected antibody producing immune cell with a cancerous 
cell using electrofusion.  In this manner, a continuous cell line is 
generated that produces the antibody of interest.  Genetic engineering 
has resulted in cells that can produce other specific protein products, 
such as Factor VIII which is used to treat hemophilia.  Substantial effort 
is dedicated to growing these specialized cell lines to harvest desired 
protein products.  While giant bioreactors are used for commercial 
production, to optimize growth conditions, smaller scale platforms are 
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utilized.  Ling et al. show a two-fold improvement in antibody production 
upon the incorporation of dimethyl sulfoxide in a 30ml shaker flask, and 
demonstrate scalability by then advancing to 10L cultures [144].  Smaller 
bioreactor vessels can perform high throughput screenings to identify 
optimal growth conditions, and most productive clones while mirroring 
large-scale bioreactor conditions [145].  Dalm et al. use bulk acoustic 
filter (BioSep) to retain hybridomas in a 3L culture vessel and 
demonstrate stable growth, and antibody production over multiple weeks 
[63].   
VACCINE AND GENE THERAPY 
A similar, but more complicated application is using cells to 
generate viral vectors for gene therapy and vaccines.  Gene therapy seeks 
to treat patients with genetic mutations, by providing them specific 
genetic material to treat the disease at the source.  To deliver the genetic 
material modified viruses are often used.  To vaccinate against viral 
disease, people are given a small amount of attenuated virus, or parts of 
the virus structure so that the immune system can recognize and 
develop immunity to the virus.  Upon being challenged with the wild-type 
strain the immune system has already been primed, and can effectively 
clear the infection.  Both these applications require large amounts of 
virus to be produced.  While vaccines are often manufactured in living 
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organisms, such as chicken embryos, cell culture platforms can be more 
flexible, and time and cost efficient.  Producing viruses in cell cultures 
adds a level of complexity as the viruses affect cell health, and requires a 
dynamic multispecies system.  Most often high levels of virus production 
results in high levels of cell death, although this is not necessarily true, 
especially for gene therapy vectors, such as lentiviruses [146].   
Similar to hybridomas, cell lines must be optimized for specific 
viruses [147].  For virus production it is even more important to carefully 
monitor culture systems.  While tremendous improvements in cell lines 
and media optimization have helped recombinant protein production 
reach production levels, the complexity of cell-virus systems suggests 
that enhanced control over the culture is necessary.  Cortin et al. 
demonstrate higher specific cell adenovirus vector production when 
cultured under perfusion conditions versus batch culture conditions 
[148].  Similarly, Ansorge et al. use an acoustic filter to retain cells and 
continuously produce lentivectors for gene therapy [146].  They measure 
bulk permittivity to monitor cell density.  Producing viruses for vaccines 
in continuous cell culture systems proves to be more difficult as the virus 
dramatically affects cell health.  The Reichl lab at the Max Planck 
Institute aims to develop a platform for continuous flu vaccine 
production.  To achieve this, a cell bioreactor is maintained in parallel 
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with a virus bioreactor to replenish the cells as the virus kills them.  
They grew influenza in this system for over two weeks [149]. 
Interestingly, they found a periodic accumulation of defective interfering 
particles (DIPs), or incomplete virions that compete with viable virions.  
DIPs cannot infect a host cell on its own, since it lacks all the 
components necessary.  However, if it is able to infect a cell with a full 
virion, it will compete for resources, and as it is much smaller than the 
full virions it replicates more quickly.  Thus, DIP generation can be 
encouraged by infecting cells at high multiplicities of infection (MOIs, 
virions per cell) [6].  This study highlights how complex viral culture 
systems are, and the importance of thoroughly evaluating generated 
virus. 
4.3 OPPORTUNITY: USING MESOSCALE SYSTEMS TO STUDY VIRUS 
EVOLUTION 
Beyond simply optimizing a procedure to be scaled to production 
scale, mesoscale cell culture systems present a unique opportunity to 
probe basic science questions, while providing insight that can be 
relevant for production scale processes.  In the section we provide a brief 
background on RNA viruses and to conclude the chapter we discuss the 
potential to use mesoscale perfusion culture systems as tools for 
elucidating viral evolution. 
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4.3.1 RNA VIRUSES 
On one hand, viruses are very simple.  Viruses are just nucleic 
acid surrounded by a protective coat.  On the other hand, they have the 
potential to demolish populations and change history.   
Viruses infect host cells, and hijack cellular machinery to make 
viral proteins and replicate.  Cellular genetic information is stored as 
DNA, and when a cell duplicates DNA polymerases make copies of this 
cellular information.  Therefore, RNA viruses cannot use host 
polymerases which read DNA, and bring with them their own 
polymerases into the cell (which are translated into functional enzymes 
by host machinery) to copy their genome.  Unlike high fidelity host DNA 
polymerases which utilize proofreading strategies, RNA polymerases are 
much more error prone, generating 10-4 errors per nucleotide copied 
[113].  This is the driving force between the high mutation rate of RNA 
viruses, and a large component of the unpredictability of emerging viral 
diseases [4]. 
In this thesis, Dengue Virus (DENV) and Sindbis Virus (SINV) are 
used to test our platform.  Both SINV and DENV are mosquito 
transmitted RNA viruses, and this category of virus represents a 
significant public health threat.  One third of emerging and re-emerging 
infections are due to RNA viruses [4].  One area of interest is studying 
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how these viruses are able to regularly alternate between insect and 
mammalian hosts.  Species-jumping is a key concern for many viruses, 
and these viruses that normally infect many host types may serve as a 
starting point in understanding different viral mechanisms of adaptation 
to new hosts.   
DENV is a category A pathogen, indicating that it “poses the 
highest risk to national security and public health” [150].  The incidence 
of Dengue has increased 30-fold over the last 50 years [151], and it is 
estimated that 2.5 billion people live in endemic areas [152].  SINV on the 
other hand, poses less of an immediate threat to human life, but is 
frequently used as a model organism to study bio-threats such as 
Chikungunya, and Venezuelan Equine Encephalitis Virus.  It is often 
used as a model of encephalitis and to study viral persistence [153].  
Different regions of the genome have been identified that are important in 
affecting host tropism; in particular regions that code for structural 
proteins important in cell receptor binding.   
4.3.2 VIRUS EVOLUTION   
As a result of the high mutation rate of RNA viruses, it may be 
more accurate to think of the virus not as a single entity, but a cloud of 
related subspecies [154].  Lauring and Andino estimate that in an RNA 
virus infection every point mutation is present at any given time [113].  
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This diversity means that viruses can more easily navigate new 
environments.  Various studies, both in the lab and by analyzing 
collected samples in an outbreak have attempted to shed light on RNA 
virus evolution.  Morley et al. seek to understand Vesicular Stomatitis 
Virus (VSV) and SINV evolution in response to being grown on mixed cell 
populations [5,155].  They find that when VSV is cultured on mixed cell 
types the overall fitness varies more than when cultured on a single cell 
type [155].  For the SINV studies they started with a permissive cell line, 
and slowly introduced a less susceptible cell type.  They found that when 
the less susceptible cell type “invaded” the environment more quickly 
less fit and more genetically diverse virions were generated [5].  They 
observed the most frequent changes in consensus sequence in the E2 
structural protein gene, with new mutations every 13 bases.  Similarly, 
colleagues have identified changes in the SINV consensus sequence in 
the E2 structural protein between virus grown in monkey kidney cells 
after just one generation in primary neural cells [156]. 
While these studies are a starting point, the small sample sizes 
(typically well plates with <10 ml) are limiting when virus evolution 
depends so heavily on the presence of many mutants.   
4.3.3 CELL-VIRUS DYNAMICS: IMPORTANCE OF MOI 
Controlling the microenvironment becomes even more important 
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when studying cell-virus interactions.  Numerous studies have pointed to 
different dynamics and outcomes depending on the conditions 
surrounding the initial infection.  For example, the influential study by 
Zeng et al. exposed that in the case of bacteriophage lambda the number 
of infecting phages per cell determines if the cell undergoes lytic or 
lysogenic infection [157].  Fischer et al. use droplet microfluidics to 
encapsulate single cells with differing amounts of norovirus [158].  By 
removing the competition between viruses by isolating each cell-virus 
pair, they observe an increase in virus titer, suggesting that this method 
can be used to study low-fitness variants and probe the inherent 
diversity within virus populations without selecting for high-fitness 
individuals.   
On the population level, passaging virus at high or low MOI can 
affect virulence.  A method to generate a low infectivity persistent SINV is 
to perform frequent passages at high MOIs to encourage the production 
of defective virions [6,156]. 
Despite the obvious importance of dynamics between single cells 
and virions, traditional virology methods involve infecting a population of 
cells and letting the infection run over the course of many virus 
generations.  This is more pronounced when cells are infected at low 
MOIs, and multiple rounds of virus infection occur before population 
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level cell death occurs.  In static cultures such as these, the MOI usually 
starts relatively low, and then as the cells die and the virus replicates the 
“instantaneous” MOI changes throughout the infection.  As other studies 
have noted the importance of MOI in guiding viral evolution, this 
uncontrollable parameter in static systems confounds results.  
Maintaining a steady-state cell-virus culture may help address some of 
these concerns.  Growing influenza in a mesoscale bioreactor (500ml), 
Frensing et al. demonstrate regular oscillations in virus infectivity, in 
comparison to chaotic fluctuations observed in serial passage infections 
[149].   
4.4 SUMMARY AND OUTLOOK 
Microfluidic culture platforms have been well established as a 
novel method to create environments that can mimic in vivo conditions.  
Small-scale bacterial chemostats highlight the importance of maintaining 
and monitoring cell state.  However, these platforms deviate drastically 
from traditional cell culture techniques, making them difficult to 
implement.  Additionally, these methods tend to be at a smaller scale, 
and most well suited to research and development applications, 
including drug screening.  In contrast, mesoscale culture systems are 
frequently used to optimize procedures that can be scaled to industrial 
processes for biopharmaceutical production. 
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In contrast to the detailed information resolved from small samples 
in microfluidic devices, when studying virus evolution larger population 
sizes may generate more relevant information.  The main mechanism of 
virus mutation and adaptation relies on large diverse virus populations.  
Thus, by performing experiments in small static culture systems, many 
important dynamics are overlooked [149].  Mesoscale systems are the 
ideal size to be manageable in research laboratory setting, integrate with 
existing techniques and infrastructures, yet obtain a large enough 
population to observe virus evolution in a robust manner.  Enhanced 
control over cell-virus dynamics opens the possibility of controlling the 
MOI over time with more precision, removing one layer of uncertainty 
that plagues current experiments.  Furthermore, insight gained from 
these experiments is immediately applicable to vaccine and gene therapy 
production.  This thesis seeks to apply the precision of microscale 
techniques to influence and manipulate large cell-virus systems to probe 





Figure 4.1 Typical length scales for cell culture systems, in liters.  
Definitions of “micro”, “meso” and “macro” scale systems differ based on 
application; here, we depict the scales discussed in this thesis.  
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Chapter 5 DEVICE DESIGN & OPTIMIZATION 
5.1 INTRODUCTION 
Our motivation is fast, continuous-flow separation for automated 
sample processing.  To achieve this, a novel design for acoustofluidic 
devices is presented.  This work represents a significant caveat in the 
field, and highlights the potential for microscale devices to investigate 
and probe basic physics.  Traditional devices assume that waves are 
reflected from silicon walls.  In contrast, our work shows that waves can 
be transmitted through walls that are sufficiently thin.   
We seek a device geometry in which the particle focusing node 
position is not constrained to the channel centerline or walls.  We 
therefore present a novel acoustofluidic configuration that allows the 
position of the pressure node within the microchannel to be arbitrarily 
chosen.  This is accomplished by subdividing the microchannel into two 
parts using a thin silicon wall, which is virtually transparent to the 
ultrasound.  This decouples the fluidic and acoustic boundaries, as both 
portions of the subdivided channel to participate in the acoustic 
resonance, but particle manipulation takes place in only one of them.  
For a given device, the location of the wall and the dimensions of the 
channels to either side define the node position, allowing particle 
focusing off the centerline.  For example, a single node can be generated 
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at 40% of the separation channel width, something not usually possible.  
Some of the design features incorporated here, such as acoustophoresis 
in subdivided channels [159,160], and acoustically transparent 
membranes in large-scale acoustic devices [161,162] have been 
demonstrated by other investigators.  Of note are several reports of 
asymmetric focusing within the microchannel [81], where the node 
position in some cases can be dynamically controlled by multi-mode 
superposition [76] or phase [82,83] or frequency [84] shifting.  None of 
these prior approaches, however, have achieved significant flow rates, 
thus being highly limited in sample throughput.  The capability of 
positioning the pressure node at a designed location relaxes the flow 
stability requirements, improves overall robustness of operation, 
enabling us to achieve high-flow, high-efficiency particle separation.  
Here, we exploit this design to perform high-throughput separations, 
however, the arbitrary node placement also opens the door to other 
applications such as affinity specific extraction in continuous flow 
[160,163].   
In this chapter, we quantify the effect of wall thickness on focusing 
efficiency and device operation.  Armed with these results, the design is 
further optimized in second-generation devices.  We show improved 
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operation reliability and high throughput focusing after incorporating 
these design improvements.   
5.2 METHODS  
5.2.1 FABRICATION 
The fluid channels of our devices have a rectangular cross-section, 
anisotropically etched 200 µm deep into <100> silicon by deep reactive 
ion etching.  The bypass channel is etched at the same time as the 
separation channel, with the single-crystal silicon separating wall 
remaining between them (Figure 5.1a).  A borosilicate glass lid is 
anodically bonded to seal the channel, and the devices are diced apart, 
giving each chip overall dimensions of 70 × 9 × 1 mm.  Ultrasound 
actuation is generated by a PZT piezoceramic (PSI-5A4E, Piezo Systems, 
Woburn, MA) glued to the silicon side with cyanoacrylate.   
5.2.2 DEVICE DESIGN 
The overall fluidic geometry follows the H-filter paradigm [105,164], 
with two inlets and two outlets for the main separation channel.  The 
chips operate at the second harmonic (full-wave resonance), since 
stronger primary radiation forces (Frad) are generated by operating at a 
higher frequency [69].  During device operation, sample and buffer 
solutions flow through the separation channel, while the bypass channel 
is filled with fluid, usually water (Figure 5.1). 
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We report on experimental results from two device generations 
(Table 5-1).  First-generation (GEN1) devices were designed to determine 
the effect of wall thickness and placement on acoustophoretic 
performance.  Since the wall location cannot be dynamically adjusted 
within a single device, wall thicknesses tW of 16, 24, 32, 40, and 80 µm 
were fabricated, and separation channel widths wmain of 750 and 650 µm 
tested for each wall width.  The combined channel widths (wT =wbypass + 
wmain) spanned 1 mm for all the devices, and focusing performance was 
compared to a 1 mm wide channel with no wall.  The separation channel 
length for all GEN1 devices was 40 mm.  For characterization of acoustic 
focusing microsphere suspensions were injected into the inlet farthest 
from the bypass channel (“input sample” in Figure 5.1b) such that 
particles would not be driven toward the dividing wall (see “GEN1” in 
Figure 5.2). 
A second generation (GEN2) of devices was optimized in several 
different ways to achieve high-throughput particle size separation.  First, 
by using the smaller channel as the separation channel, the Frad force 
vectors point away from channel walls at all locations (Figure 5.2).  
Second, these devices incorporate the thinnest walls that can be reliably 
fabricated without defects – 16 µm thick.  Finally, two versions of GEN2 
devices were fabricated.  Devices with a single pass (40mm in length), 
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and devices with three switchback passes down the microfluidic chip, 
with a total channel length of 117 mm, increasing sample residence time 
in the acoustic pressure field.  In GEN2 devices, the total fluid channel 
width wT is 900 µm, with separation channel widths wmain of 300 µm and 
280 µm.  As in the GEN1 devices, the sample to be processed is 
introduced on the side farthest from the bypass channel, with the largest 
particles migrating into the clean buffer stream for extraction out of the 
large-particle outlet (LPO), while smaller particles do not experience 
sufficient acoustic force, remaining in the input stream (SPO).    
5.2.3 ANALYTICAL SOLUTION: ONE DIMENSIONAL WAVE MODEL 
To estimate the effect of the wall, as well as different solutions in 
the main and bypass channel a simple one dimensional representation of 
our system is useful.  The resonant frequencies are defined as the 
frequencies when a standing wave is generated within the channel, 
which occurs when the acoustic waves interfere constructively.  Two 
interfering waves with equal amplitude, 
𝐴0
2
,  and frequency, ω, traveling in 
opposite directions can be written as 
𝑦 = 𝐴0 cos(ω𝑡) sin(𝑘𝑥)  
Where 𝑘 is the wave number, 𝑘 =
2𝜋
𝜆
, and 𝑥 is the position variable.  
The acoustic waves travel through the silicon walls, and at the resonant 
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frequency generate velocity nodes (pressure anti-nodes) at the channel 
walls, and impart pressure onto the fluid.  This constrains the above 
equation to be equal to 0 at 𝑥 =0 and 𝑥 = 𝑤 , were 𝑤  is the channel 
dimension.  Therefore, resonant frequencies occur when 𝑤 =
𝑛𝜆
2
 𝑓𝑜𝑟 𝑛 =








Equation 5-1 Resonant frequency 
in traditional BAW resonators, where 𝑣 is the speed of the wave, which in 
our case is equal to 𝑐, the speed of sound in the medium.  In our device, 
we can estimate the effective “water equivalent” channel width, 𝑤𝑒𝑓𝑓 , 
depending on the thickness of the silicon wall, 𝑡𝑤, width of the bypass, 
𝑤𝑏𝑦𝑝𝑎𝑠𝑠, and main channel, 𝑤𝑚𝑎𝑖𝑛 (Figure 5.2).   The results presented in 
this chapter use water in both the main and bypass channel. 




Equation 5-2 Effective Water Channel Width 
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, 𝑛 = 1,2, … 
Equation 5-3 Focusing Position 
intervals along the channel length. 
We use Equation 5-2 and Equation 5-3 to estimate the resonant 
frequency and node location, shown as dashed lines in Figure 5.4a and 
b . 
5.2.4 EXPERIMENTAL SETUP 
All experiments were carried out on an inverted fluorescence 
microscope (Axiovert S100, Zeiss, Jena, Germany) with the acoustofluidic 
chip clamped to a custom-machined stage interface board, and tubing 
attached using custom gasketed fluidic fittings (see Figure 7.1) [165].  A 
function generator (33220A, Agilent, Santa Clara, CA) provided the 
sinusoidal excitation signals, amplified by an RF amplifier (410LA, ENI, 
West Henrietta, NY) to drive the piezo actuator.  A cooled CCD camera 
(CoolSnap HQ2, Photometrics, Tucson, AZ) captured fluorescence 
images.  Samples were pumped through the device by conventional 
syringe pumps (PHD 2000, Harvard, Holliston, MA) or by high-precision 
metering syringe pumps (MicroFlow, Micronics, Redmond, WA). 
 62 
Several recent reports have emphasized the importance of 
temperature control for stable acoustophoretic device operation [70,166].  
Operating un-cooled, our device temperature can rise to 70°C or higher, 
so we use a small fan attached approximately 2 cm above the device to 
provide air cooling.  This open-loop cooling approach is less complex 
than active feedback thermoelectric temperature control, and provides 
sufficient stability, limiting temperature variations to less than 2 °C for a 
given frequency and driving voltage, based on attached thermocouple 
measurements. 
5.2.5 IN SITU CALIBRATION: RESONANT FREQUENCY, FOCUSING EFFICIENCY  
To supplement analytical predictions based on geometric 
calculations, accounting for any temperature effects, and variations in 
fabrication or piezo attachment, the devices were experimentally 
evaluated using an in situ calibration method.  A full description of this 
method is detailed in Chapter 7.2.2 as part of our automation platform.  
Briefly, the chip is excited at different frequencies, and fluorescent beads 
are pumped through the device and images are captured at each 
frequency.  The average total flow rate used to characterize each chip was 
75 μL/min (20mm/s), and the applied voltage was approximately 18Vpp.  
(See Chapter 7.2.2 for additional details.)  Flow speed is calculated from 
channel dimensions and the total volume passing through the channel 
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where the acoustic pressure field is active, taking into account sample 
and any co-flowing buffer.  The resulting images are analyzed to 
determine f0, peak location, and quantify the focusing efficiency.  For a 
quantitative measure of particle focusing in GEN1 devices, focusing 
efficiency is calculated by integrating the intensity profile within ±25 µm 
of the peak location, normalized by the total intensity within the channel 
(not all GEN1 devices exhibited high quality focusing with Gaussian 
single-peak, intensity profiles).  Higher values reflect better performance.  
For GEN2 devices, a Gaussian is fitted to the intensity profile at the peak 
frequency, and the full width at half maximum (FWHM) is used as a 
measure of focusing efficiency, with lower values representing better 
performance (Figure 5.3).   
5.3 RESULTS 
5.3.1 EFFECT OF THE WALL: FOCUSING PERFORMANCE GENERATION 1 
DEVICES 
Figure 5.4 summarizes the results of in situ focusing 
measurements from 18 distinct GEN1 devices, spanning 11 different 
design configurations, with walls of different locations and thicknesses, 
𝑡𝑊.  As expected, the resonant frequency f0 increases with increasing 𝑡𝑊.  
This is because the wall reduces the effective channel width, weff, due to 
the six-fold faster speed of sound in silicon relative to water. Resonant 
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frequencies are then calculated using Equation 5-1 and Equation 5-2, as 
𝑓0 = 𝑛𝑐𝑤 2𝑤eff ⁄ , where n is the number of pressure nodes (2 for our 
device).  The expected values f0 are shown in Figure 5.4a by a dashed 
line, calculated for temperatures of 30 °C and 40 °C.  The average f0 
measured in 1mm chips with no wall is 1.49 MHz, and experimentally 
measured values generally match predicted values better for thinner 
walls.  This first-order analysis is certainly an incomplete model of 
resonance within the full 3-dimensional physical system, and 
underestimates f0 for thicker wall widths, but provides useful estimates 
when the wall is thin (Figure 5.4a). 
Figure 5.4b shows pressure node locations, measured from the 
nearest channel wall, along with calculated locations based on the values 
of weff.  As with the peak frequency data, thinner walls are in closer 
agreement with calculations, and with less overall scatter in the 
measured data.  Finally, as expected, Figure 5.4c confirms that 
increasing the wall thickness beyond 30 µm has a negative impact on 
focusing efficiency, in some cases severely.  The notable exceptions to 
this general trend are the devices with 750 µm separation channels and 
80 µm and 40 µm walls (referred to as “750-80” and “750-40” devices).  
These perform very well, relative to their wmain = 650 µm counterparts, 
though not quite as well as thinner wall chips.  The probable reason for 
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this, as well as for the relatively large overall scatter in the data for GEN1 
devices is the quality and thickness of the adhesive layer between the 
piezo actuator and the silicon.  This parameter of device assembly was 
not tightly controlled in GEN1 devices compared with GEN2 devices.  The 
750-80 and 750-40 chips likely had exceptional acoustic coupling 
properties relative to the other GEN1 chips.  We similarly attribute the 
substantial differences in peak frequency and node position for the 𝑡𝑊 = 
32 µm devices to piezo attachment variations.  
In spite of the variability in these trends, the data in the aggregate 
points toward thinner walls allowing higher-efficiency focusing with less 
dependence on wall position (Figure 5.4b, c).  Minimizing wall thickness 
𝑡𝑊 ensures that the focusing position can be designed without regard to 
the wall, and the wall’s effects on operating frequency and separation 
efficiency can be neglected.  For this reason, all GEN2 devices were 
designed with 16 µm walls, which is the thinnest that can be reliably 
fabricated. 
5.3.2 GENERATION 2 DEVICES: OPTIMIZED PERFORMANCE 
ACHIEVING ARBITRARY NODE PLACEMENT: WALL LOCATION DOES NOT AFFECT 
FOCUSING 
To demonstrate arbitrary node placement, two versions of GEN2 
devices were fabricated with 𝑤𝑚𝑎𝑖𝑛=300 and 280µm.  By changing the 
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wall position we can achieve arbitrary node placement within the main 
channel, although with respect to the total channel width the node 
position remains constant.  We find that the node location and focusing 
efficiency between the different designs does not differ significantly 
(Figure 5.5). 
OPTIMIZING PIEZO ATTACHMENT   
 Prior to assembly of GEN2 devices, we developed a procedure for 
dispensing a controlled volume of low-viscosity cyanoacrylate without 
introducing voids or thickness non-uniformity, in comparison to high-
viscosity adhesive used with GEN1 devices.  A direct performance 
comparison between identical devices before and after the improved 
adhesive procedure is shown in Figure 5.6.   
HIGH FLOW FOCUSING 
The improved coupling of the piezo transducers to the acoustic 
chips in GEN2 devices, results in more consistent delivery of acoustic 
power to the channel, and allows for better focusing at faster flow rates 
in comparison to GEN1 devices.  Even at high flow rates (200µL/min, 60 
mm/s) particles can be focused at moderate voltages in 3-pass devices 
(Figure 5.7). 
Overall, the enhanced performance of GEN2 devices is apparent 
from the significantly tighter error bars for both the focusing location and 
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FWHM data, even at lower voltages and higher flow speeds than those 
used to characterize GEN1 devices.  
5.4 DISCUSSION 
5.4.1 DESIGN OPTIMIZATION 
The results of this study provide validation for the “transparent 
wall” approach to acoustofluidic device design.  As intended, the 
subdivision of the resonant fluid volume allows the effective de-coupling 
of the acoustic and fluidic boundaries of the device.  Asymmetric 
placement of a single pressure node is possible, by choosing a resonance 
condition for the overall combined channel, and placing the subdividing 
wall in the location optimal for the separation.  The results of the study 
with GEN1 chips yield useful practical parameters for using this approach 
to design a high-efficiency particle separator.  The GEN1 results also 
highlight the importance of reliable transducer attachment. 
The overall trends among the GEN1 devices suggest that thinner 
walls lead to improved focusing efficiency and closer correspondence 
between predicted (calculated) and measured focusing location and 
frequency.  Moreover, though thicker-wall chips presented significantly 
different results for different separation channel widths wmain, chips with 
thinner walls showed greater consistency (smaller error bars) for all 
focusing metrics.  This suggests that even with suboptimal coupling of 
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the piezo transducer, thin-walled chips (20 µm or less) behave very 
nearly like devices without walls.  We hypothesize that the vibrational 
modes of the walls themselves (acting as a plate resonator at frequencies 
different from the overall channel resonance) interfere with particle 
focusing when walls are thicker and have greater mass. More massive 
walls propagate more acoustic energy at the non-focusing frequencies, 
interfering with efficient transmission of energy at the focusing 
frequency.  A limited numerical study using finite-element methods 
shows partial evidence for this supposition hypothesis, however, further 
investigation is necessary within the context of these designs.  The 
present empirical study nevertheless provides the acoustofluidic device 
engineer with reliable design parameters for laying out fluid channel 
networks with predictably positioned off-center nodal locations. 
5.4.2 HIGH THROUGHPUT FOCUSING (GENERATION 2 DEVICES) 
In second-generation devices, in addition to characterizing the 
overall device performance and reliability across multiple chips, we 
evaluated the benefit of three passes of the fluid channel down the chip 
(117 mm total length) by comparing the performance to identical 40 mm 
long devices (1-pass wmain = 300 µm), shown in Figure 5.7.  As expected, 
single-pass devices perform less well than three pass devices, requiring 
higher voltages to approach the node position, and never achieving the 
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same tightness of focusing.  Notably, there is good agreement between 
experiments in which beads have approximately the same on-chip 
residence time, in single-pass devices at 20 mm/s (blue squares, dashed 
lines) and three-pass devices at 60 mm/s (red circles, dotted lines).  
Therefore, the beads’ lateral migration speed across streamlines is 
consistent between the different devices, and these data serve to validate 
the robustness of the overall design approach.  Similarly significant is 
the comparison between identical GEN2 devices with their wall locations 
differing by 20 µm, shown in Figure 5.5.  There is no meaningful 
difference between the focusing locations and efficiencies in these 
devices, confirming that the acoustic resonance can be designed with no 
effect from the wall. 
The data in Figure 5.5 and Figure 5.7 also indicate the similarities 
across all three GEN2 designs.  At higher operating voltages, particles 
migrate closer to the predicted focusing location approximately 225 µm 
away from the wall (weff/4), and the FWHM of the focused particle stream 
tightens.  Finally, the data with the field off (0 Vpp) do not show a 
significant difference between the single-pass and three-pass chips, 
indicating that the serpentine design does not introduce significant 
mixing (e.g. by Dean vortices) to degrade separation performance at flow 
speeds up to 60 mm/s (Figure 5.7). 
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5.5 CONCLUSIONS 
In summary, an acoustic separation microdevice with the unique 
feature of custom-designed asymmetric node positioning within the 
separation channel has been developed.  This has the benefits of relaxed 
flow and temperature control requirements, and reduced acoustic power 
demands. 
We have confirmed the validity of this design approach by 
fabricating a variety of devices and exploring their focusing performance 
for a range of parameters.  Further optimization was guided by these 
performance results, and resulted in enhanced device performance.  The 
resulting device is extremely robust and versatile.  Since the silicon and 
glass are chemically inert rigorous cleaning procedures can be used, and 
device lifetime is mostly limited by user error (physically damaging the 
chip).   
Overall, this novel design for acoustofluidic devices challenges 
prevailing assumptions about acoustic wave propagation, enables high-
velocity robust separation, and tunable operation.  We believe that this 
design advances the versatility of acoustofluidic devices.  The engineered 
node location enhances stable operation, and results in the capacity to 
perform high-throughput separations.  We anticipate useful application 
of these devices in many contexts, especially where large samples must 
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be processed, and with unknown samples.  In the following chapter we 
demonstrate particle separation with finely tuned second-generation 





Figure 5.1 Acoustofluidic device and schematic of operation. (A) 
Image (left), and scanning electron micrograph cross-section (right) of a 
generation 2 device. (B) top view, showing overall H-filter configuration, 
with relative channel locations (not to scale). The insets at the bottom are 
fluorescent micrographs of a mixture of 10 mm red-fluorescent and 200 




Figure 5.2 Focusing Modes in GEN1 and GEN 2 Devices. Schematic 
drawings of the channel cross section showing the relative locations of 
the sample, buffer and bypass streams, and acoustic pressure node 
locations for GEN1 and GEN2 devices. The red dotted lines represent the 
full-wave (n = 2 in Equation 5-1 and Equation 5-3) pressure field in the 
channels and the red arrows indicate the sense of the acoustic primary 




Figure 5.3 Measuring Focusing Efficiency in GEN1 and GEN2 devices.  
Representative heat-map plots from the results of in situ frequency 
sweeps for gen1 devices with wSEP =650 µm and (A) 16 µm and (B) 80 µm 
walls.  Channel walls are outlined with white dashed lines and peak 
frequencies and locations are indicated by circles, with the intensity 
profile for the segment indicated by the red dashed line at each peak 
frequency shown in the insets.  For GEN1 devices, the shaded area within 
±25 µm of the peak location is used for quantifying focusing efficiency, 
since some device showed poor focusing as in (B). The focusing 
efficiencies are 0.901 and 0.294 respectively.  To quantify the focusing 




Figure 5.4 First-generation (GEN1) in situ characterization. (A) peak 
frequency, (B) focusing efficiency and (C) focusing location for different 
wall widths tw and separation channel widths wmain.  Error bars represent 
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one standard deviation for n=3 or greater.  Dashed lines are calculations 
based on the speed of sound in silicon and water.  In (A) the upper 
dashed line is calculated at 40 °C, and the lower line at 30 °C, while in 





Figure 5.5 Wall location does not impact focusing. Characterization 
and comparison of 3-pass GEN2 devices with walls at different locations, 
wmain=280 and wmain=300 µm, showing (A) peak location and (B) focusing 




Figure 5.6 Low viscosity glue results in better acoustic coupling. 
Characterization and comparison of a 3-pass, wmain=280 µm GEN2 device 
before (high viscosity, circles, dotted line) and after (low viscosity, 
squares, dashed line) optimizing the piezo transducer gluing procedure, 
showing (A) peak location and (B) focusing width.  Average linear flow 




Figure 5.7 High Flow Focusing. In situ characterization data comparing 
1-pass (squares, dashed lines) and 3-pass (circles, dotted lines) GEN2 
devices, showing (A) peak location and (B) focusing width.  Average linear 
flow velocity for points shown in red was 60 mm/s and blue 20mm/s. 
Data for 1-pass devices represents at least n=6 measurements, while for 





Table 5-1 Summary of GEN1 and GEN2 designs 
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Chapter 6 IN SITU NODE TUNING & HIGH THROUGHPUT SEPARATION  
6.1 INTRODUCTION 
In the previous chapter we discussed a design for a novel method 
of acoustic particle focusing using a “transparent wall”.  Our goal is to 
apply these methods to achieve fast, continuous virus isolation.  
Enrichment and purification of viral particles typically requires multiple 
centrifugation steps which require significant hands-on time, and/or 
membrane-based filtering, which incurs substantial loss of virions.  Here, 
we describe how we have taken advantage of the unique sub-divided 
channel to achieve high-throughput sample separations and achieve in 
situ node tuning.  The subdivided channel allows us to manipulate the 
acoustic wave with different mediums and gives us dynamic control over 
the node position, without the complexity of frequency or phase 
modulation.   
We characterize device functionality using microspheres, and 
demonstrate its utility with biological samples by successfully separating 
cell-free Dengue virus (DENV) from human lymphocytes.  Cells are 
extracted into a clean buffer stream separate from the viruses, 
accomplishing more efficient cell extraction and cleaner spatial 




6.2.1 NODE TUNING 
The approximation for effective channel width presented in 
Chapter 5 (Equation 5-2) can be further refined when materials other 
than water are used in the bypass and main channel by taking into 
account the speed of sounds of the materials in the different channels, 
𝑐𝑚𝑎𝑖𝑛 and 𝑐𝑏𝑦𝑝𝑎𝑠𝑠 
𝑤𝑒𝑓𝑓 = 𝑤𝑚𝑎𝑖𝑛 (
𝑐𝑤
𝑐𝑚𝑎𝑖𝑛
) + 𝑤𝑏𝑦𝑝𝑎𝑠𝑠 (
𝑐𝑤
𝑐𝑏𝑦𝑝𝑎𝑠𝑠




Equation 6-1 Effective Channel Width 
Figure 6.1 shows cross-sectional sketches of the sound pressure 
field with different fluids filling the bypass channel, based on the above 
approximation superimposed on captured images of device as fluorescent 
beads are being focused in the main separation channel.  We used 
ethanol, water and glycerol as bypass fluids to allow a wide range of 
adjustment for the acoustic node position, since their sound speeds differ 
significantly (approximately 1015, 1530, and 1920 m/s at 43 °C for pure 
ethanol, water, and glycerol, respectively).  With water, the pressure node 
is located approximately 75 µm from the wall in the separation channel, 
and fluids with faster and slower sound speeds shift the node farther 
from and closer to the wall, respectively.  We have tested our device with 
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water, phosphate buffered saline (PBS) and 70% (v/v) ethanol in the 
separation channel; however, any combination of sample and bypass 
fluid may be used regardless of compatibility, since they are separated by 
an impermeable wall.  This enables tuning of the node position for 
unknown sample fluids. The majority of the experiments presented in 
this thesis use water or physiological solutions (PBS, cell media) in both 
the main and bypass channel, whose speeds of sound do not differ 
significantly from water.  Unless otherwise noted, it is assumed that 
there is water in the both channels. 
6.2.2 SIMULATED MODEL: TWO DIMENSIONAL FINITE ELEMENT SIMULATION 
A simple first order approximation of our system is an extreme 
simplification of the real physical solution, neglecting many important 
material properties, and simply reducing the system to one parameter: 
the speed of sound in different materials.  Therefore, we used COMSOL 
(Burlington, MA) to investigate the effect of different fluids in the bypass 
channel in two dimensions using the acoustic-solid interaction module, 
which incorporates the material properties of the solid silicon wall 
(Figure 6.2).  For the details of the model see the appendix, COMSOL 
Acoustic-Solids Model.  Briefly, the two fluidic channels are simulated 
using pressure acoustics, and the thin dividing wall is modeled using 
solid mechanics.  The boundaries defined by the silicon and glass walls 
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are constrained to be hard sound boundaries and reflect the acoustic 
wave, with the exception of the thin subdividing wall.  The ends of the 
dividing wall are assumed to be fixed with no movement.  To couple the 
acoustic and mechanic domains the pressure field generated by the fluid 
imparts a stress on the dividing wall, and the displacement of the wall 
imparts a pressure on the fluid domains.  Simulations were conducted at 
43˚C based on thermocouple measurements for experiments conducted 
at 20Vpp.   
6.2.3 SEPARATION EFFICIENCY QUANTIFICATION WITH BEADS 
A thorough characterization of a device is presented in Figure 6.4 
and Figure 6.5.  In these experiments various bead solutions are 
processed at different flow and voltage conditions.  A suspension mixture 
of particle sizes was prepared at approximately 0.01% w/v for each bead 
size, with .05% v/v Tween 20 to prevent beads from aggregating.  First, a 
calibration curve was run on a 3-pass GEN2 chip with wmain = 300 µm to 
identify the resonant frequency.  The efficiency, 𝜀 , of separation for 
multiple bead sizes at different voltages was determined when the sample 
inlet flow was 100 µL/min (total flow of 200 µL/min) corresponding to an 
total average flow speed of 60 mm/s (Figure 6.4).  The efficiency of 𝑖 is 
calculated as the proportion of the number of 𝑖 particles exiting from the 
large particle outlet divided by the total number of 𝑖 particles exiting the 
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chip.  This definition takes into account unequal flow split between the 
small and large particle outlet, and gives a better representation of 
concentration effects compared to comparing measured concentrations 





Equation 6-2 Separation Efficiency 
Data in Figure 6.4, Figure 6.5, Figure 6.6, and Figure 7.7 is presented as 
a percentage, 𝜀 × 100%.   
Processed samples were collected from both outlets of the 
separation channel and their bead content quantified by flow cytometry 
(Microcyte, Aber Instruments, Wales).  Next, seeking to explore the 
performance limits of this device at high flow rates, sample inlet flow 
rates between 100 and 810 µL/min were tested (n=3), corresponding to 
total flows in the separation channel between 200 µL/min and 1.6 
mL/min, and equivalent to average flow speeds of 60 to 450 mm/s, at 16 
Vpp driving voltage (Figure 6.5).   
6.2.4 CELL-VIRUS SEPARATIONS 
As a demonstration of the benefit of these devices for size- 
separating biological particles, samples of human Raji lymphocytes  (5-8 
μm diameter [167]) and Dengue virus particles (50 nm diameter [168]) 
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were processed.  Raji cells (ATCC, Manassas, VA) were cultured in RPMI 
1640 growth media supplemented with 10% fetal bovine serum at 37 °C 
and 5% CO2.  For experiments, cells were re-suspended in 1x PBS.  Cells 
were kept at room temperature during experiments.  Dengue virus, 
serotype 2 was grown in Vero cells, purified, and concentrated to an 
estimated 108 PFU/mL, and kept as frozen stock at -80 °C until needed 
for experiments.  Control experiments were first carried out with pure 
virus and pure cell samples to determine baseline results when the two 
particle types do not interact with each other.  Then cell samples 
(approximately 105/mL) were spiked with viruses (approximately 105 
PFU/mL), and processed through the device. Whole viruses were diluted 
1:1000 from frozen stock into either 1xPBS (virus only experiments) or 
Raji cell suspensions (spiked experiments).  Three trials were carried out 
for each of the pure and spiked samples with the acoustic field both on 
and off.  A 3-pass GEN2 device with wmain = 300 µm was used for these 
experiments, at 100 µL/min sample flow rate, and 16 Vpp driving voltage 
when the acoustic field was active.  Prior to processing each set of 
samples, the fluidic system was incubated with fresh cell media for a 
minimum of 20 minutes, to coat interior chip and tubing surfaces, 
thereby minimizing nonspecific cell and virus adsorption.  Cell 
quantitation before and after sample processing was accomplished by 
Coulter counting (Z2, Beckman Coulter).  Relative viral load was 
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measured by quantitative reverse-transcription polymerase chain 
reaction (qRT-PCR), comparing threshold cycle (CT) values of collected 
samples to input CT values in order to determine the percentage exiting 
each outlet (See Chapter 9.2.4 PCR amplification for an in depth 
description of PCR protocol, and Table 9-1 for specific primer and probe 
information.)  
6.3 RESULTS 
6.3.1 IN SITU NODE TUNING WITH DIFFERENT FLUIDS 
Our unique device design presents the opportunity to investigate 
how acoustic waves propagate through different materials, as the main 
and bypass channel can be filled with various fluids.  Approximating the 
channel structure as a 1-D model, we calculated the predicated node 
positions and 2nd harmonic resonant frequencies analytically by using 
the relative speed of sound in each medium for water and 70% ethanol in 
the main channel using Equation 6-1  (Figure 6.3, lines).  Using the 
acoustics-solid interaction module in COMSOL the fabricated 
microstructure was simulated in 2-D with various concentrations of 
ethanol and glycerol in the bypass channel and water or 70% ethanol in 
the separation channel to validate the 1-D model (dots).  Figure 6.2 
shows simulated pressure field amplitudes for a subset of simulated 
conditions.  Confirmatory focusing experiments were performed using 6 
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and 7 µm polystyrene microspheres in water, PBS and 70% ethanol, with 
various fluids in the bypass channel, and experimental results are 
overlaid in Figure 6.3 as open markers. The simulation data shown in 
Figure 6.3b represent the minimum of the pressure amplitude across the 
channel centerline, however due to the taper of the wall the actual 
pressure node position varies across the height of the channel (Figure 
6.2), which may contribute to discrepancies between observed and 
predicted focusing positions.  When high concentrations of ethanol are in 
the bypass channel, the 2-D finite element model predicts that the 
pressure node will be split between the separation channel and bypass 
channel, and local minima in the pressure amplitude are observed on 
either side of the wall.  (Figure 6.2, ethanol in bypass).  In these cases 
the experimentally found focusing position is along the wall (Figure 6.1 
and Figure 6.3, 100 and 90% ethanol in the bypass).  When 70% ethanol 
is in the main channel and 90% ethanol is in the bypass, the 2-D model 
does not predict splitting of the pressure node, and the experimentally 
observed focusing position matches the 2-D model predicted position.     
6.3.2 DEVICE TUNABILITY: ADJUSTABLE PORE SIZE 
Next, the device separation is quantified.  Figure 6.4 highlights the 
ability to discriminate between different particle sizes by tuning the 
operating voltage.  Similarly, one can isolate different sized particles by 
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adjusting the flow rate, and Figure 6.5 shows the extraction results for 
separating microspheres of different sizes at high flow speeds.  
Significantly, 10 µm beads are extracted at 90% efficiency even at 250 
mm/s, which corresponds to a sample input flow of 450 µL/min.  With 
buffer flowing at the same rate, the total flow is 900 µL/min.  To our 
knowledge this is the greatest linear flow velocity and one of the highest 
volumetric flow rates among any acoustophoretic devices that have been 
reported to-date (Table 6-1).   
6.3.3 CELL-VIRUS SEPARATIONS 
Figure 6.6 presents the separation results of processing Raji cells 
and Dengue viruses through the chip.  The black-outlined segment of 
each bar represents the outlet from which those particles are intended to 
exit.  With the acoustic field on, cells are successfully extracted into the 
clean buffer stream, at over 97% purity for cell- only samples as well as 
for cells spiked with virus (Figure 6.6, “Cells-Pure Sample” and “Cells-
Mixture”).  Viruses, however are more likely to move into the clean buffer 
stream when cells are present in the solution.  Without cells, only 10% of 
viruses are collected at the LPO, whereas with cells present, this figure 
rises to 32%. With the acoustic field turned off the cells and virus are 
collected at over 97% purity in the SPO, with less than 2% of either cells 
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or viruses exiting from the LPO, indicating very low diffusion across 
streamlines. 
6.4 DISCUSSION 
6.4.1 IN SITU NODE TUNING 
The divided channel design allows us to use different fluids in the 
main and bypass channel, and results in predictable node shifting, thus 
expanding the versatility of a single device.  Experimental results indicate 
that a simple one dimensional wave model of the system is sufficient to 
estimate node location with different fluids.  Water and PBS behave 
similarly with respect to acoustic wave propagation, which implies a 
calibrated device could be used with most biological samples, without 
knowing the exact sample composition a priori.  Thus, this method may 
be used to process unknown biological samples, as will be discussed in 
Chapter 7.3.3.2.  Model and experimental results with 70% ethanol in 
the main channel show that the node position can be adjusted for a wide 
range of materials in the separation channel.  However, as with most 
microfluidics, complex samples which act more as a viscoelastic solution 
rather than a simple fluid, will likely be more difficult to process.  While 
in this work we investigated acoustic propagation through relatively 
common laboratory fluids, due to the chemical inertness of silicon and 
glass this device design has the potential to be used with more exotic 
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chemicals.  This capability is useful for multiple reasons.  Firstly, 
examining acoustic wave propagation in different materials can help 
parse out the unique phenomena that occur in our chip.  Further, the 
ability to use a wide range of material in either channel means this 
device can be useful in a wide range of applications, for example, for 
“intelligent synthesis” of semiconductor nanoparticles [109].    
6.4.2 LARGE OPERATION SPACE: MANY KNOBS TO TURN 
Equipped with these design parameters, successful optimization of 
a through-the-wall type device for high-flow separation was 
demonstrated with the second device generation.  While generating an 
acoustic field is more complex than other hydrodynamic based 
separation techniques, the throughput can be decoupled from the 
separation efficiency by using higher operating voltages to compensate 
for shorter particle residence times.  As an active technique, it is possible 
to tune the effective “pore size” of the acoustic filter [101], by adjusting 
the voltage.  Combined with the fluid dependent node shifting, a single 
device can be run in many modes.   
Furthermore, this design approach achieves excellent separation 
performance at very high flow rates. Table 6-1 summarizes flow data 
form some of the highest-throughput acoustofluidic devices reported to-
date.  The data is selected for conditions at which the devices achieved 
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90% or better extraction of 10 µm (or similar) particles.  The present 
design not only attains the highest flow speed in the separation channel, 
but has one of the highest volume throughputs as well.  While volume 
throughput is certainly a critical metric, the flow speed is perhaps a more 
direct measure of how efficiently the acoustic field moves particles within 
the channel.  Significantly, the devices that come closest to matching the 
present design in linear velocity lag far behind in sample flow rate (6-10x 
lower) due to much smaller channel dimensions [98] or high dilution 
factors [96,97].  The approach in the present work is therefore a unique 
combination of high separation efficiency with high throughput. 
6.4.3 BIOLOGICAL SAMPLE SEPARATIONS 
These devices also show high separation efficiency when 
manipulating biological particles.  Acoustic actuation efficiently extracts 
Raji cells from the input stream into a separate outlet (Figure 6.6).  This 
is in line with a multitude of recent reports of efficient acoustophoretic 
manipulation of many different cell types [75,97,98].  The goal for viral 
particles is that they will not be moved by the acoustic field, remaining in 
the original fluid stream and exiting in the SPO.  Overall, this is how the 
virions behave, but the full picture is more nuanced.  When the acoustic 
field is turned on, many more viral particles exit from the LPO than when 
the field is off, even for pure viral samples (less than 2% with no field, 
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and 10% at 16 Vpp).  We conjecture that this is due to acoustic 
streaming, which dominates the transport of sub-micron particles and 
generally requires high actuation power to induce appreciable particle 
movement [169].  We see some evidence to support this conjecture in 
Figure 6.4, where approximately 10% of the smallest particles are 
extracted at the highest actuation power. 
Moving beyond purified viral samples, adding cells into the sample 
mixture increases the fraction of viral genetic material detected in the 
LPO to approximately 30%, thereby limiting separation efficiency (Figure 
6.6).  This is to be somewhat expected as cells migrating across 
streamlines due to the acoustic radiation force can drag the much 
smaller viral particles with them, and induce fluid transfer from the 
sample stream to the buffer stream despite low Reynolds numbers.  
Although DENV has been shown to infect Raji lymphocytes [170], we 
expect the majority of the viral transfer to the LPO is due to 
hydrodynamics.  In our experiments, significant cell infection (viral entry 
into cells) is not expected to take place, as viruses were spiked into the 
cell suspension shortly before separation, giving the viruses and cells no 
more than 20 minutes together.    
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6.5 CONCLUSION 
The asymmetric node design increases the stability of device 
operation, enabling extremely high-throughput particle size sorting, and 
high-purity separation of biological particles.  Additionally, device 
versatility is enhanced by using different fluid media in our subdivided-
channel acoustofluidic.  This results in predictable shifting of the node 
position and the resonant frequency, enabling a single device to be used 
for multiple applications. 
We successfully demonstrated high-speed separation, and removal 
of cell removal from cell-virus mixtures.  Thus, these devices have the 
potential to be impactful in contexts in which enrichment or purification 
of viral particles from mixed and particle-contaminated samples is 
required.  For example, these methods can be used to enrich for the viral 
content of samples such as serum (clinical), wastewater (industrial), and 





Figure 6.1 Using effective channel width to predicted node position.  
Analytically predicted node positions (blue dotted line) from Equation 6-1 
super imposed on captured images of fluorescent beads being focused 
with different fluids in the bypass channel.  The separation channel has 
water in it.  Sound waves in a fluid with lower sound velocity have a 




Figure 6.2 Simulated pressure field. COMSOL simulation of pressure 
amplitude at the second harmonic frequency with ethanol, water and 
50% glycerol in the bypass channel and water in the separation channel 
(top) and scanning electron micrograph cross section of device (bottom). 
Blue is low and red is high pressure.  In the COMSOL model, the wall 
thickness tapers from 6 µm at the top to 13 µm at the bottom, based on 




Figure 6.3 In situ node tuning. Analytical (lines), simulated (dots), and 
experimental (open symbols) results of using fluids with different sound 
velocities in the device.  Legend indicates fluid in the separation channel. 
(A) Resonant Frequency.  Error bars are the step size of the frequency 
sweep performed to determine resonant frequency, except when good 
focusing is observed over a large frequency range.  In this case the error 
bars span this range.  (B) Focusing Position.  Error bars are SEM, n=3 or 





Figure 6.4 Device Tunability: Particle Size and Voltage Effects. 
Percent of polystyrene microspheres extracted in the LPO depends on the 
particle size and voltage supplied to the piezoceramic.  Each line 
corresponds to a different operating voltage at the resonant frequency.  
Total flow rate through the device is 200 µl/min (flow speed is 60mm/s), 
with applied drive frequencies between 1.62 and 1.64 MHz.  Error bars 




Figure 6.5 Pushing the limits: High throughput separation. 
Extraction of polymer microspheres of different sizes in the LPO (clean 





Figure 6.6 Cell-Virus Separations. Fraction of collected bio-particles 
extracted in the small (SPO) and large (LPO) particle outlet when 
operated at 16Vpp.  Thick black borders indicate the intended outlet for 
each particle type.  Error bars are SEM, n=3.  When the acoustic field is 
off, greater than 98% of all particles exit from the SPO in both purified 






Table 6-1 Summary of high throughput acoustophoretic separators.  
Volume throughput and flow speed of the present device design in 
comparison to previously-reported high-throughput acoustophoretic 
separators.  
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Chapter 7 PLATFORM DEVELOPMENT: SYSTEMS INTEGRATION AND 
AUTOMATION 
7.1 INTRODUCTION 
A major advantage of microfluidic devices is the ability to 
manipulate small sample volumes, thus reducing reagent waste and 
preserving precious sample.  However, to achieve robust sample 
manipulation it is necessary to address device integration with the 
macroscale environment.  Although many microfluidic separation 
technologies have been extensively characterized, few reports have 
considered device operation at a system level.  Devices are typically 
individual centimeter-scale chips, interfaced to fluoropolymer tubing and 
rely on fluid delivery by a displacement or pressure pump.  Yet, if the 
promise of microfluidics–including increased automation, reliability, and 
reduction in sample volumes–is to become reality, the design of a 
complete separation system into which microfluidic devices are 
integrated must be addressed.  
Taking a system-level view, this chapter details a system 
architecture developed to: 1) Establish design guidelines for modular 
device design and operation, and robust chip-to-world interfacing.  2) 
Perform a full parameter sweep of acoustofluidic devices and determine 
the optimal operating conditions and quantify its performance 
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characteristics.  3) Reliably process precisely-metered analytical-scale 
volumes (ranging from 0.15 to 1.5 mL) on ~10 minute timescales.   
7.2 METHODS 
7.2.1 WORLD-TO-CHIP INTERFACE 
To address some of the challenges of interfacing between the chip 
and the world, some key design guidelines are implemented.  A custom 
“fluidic breadboard” which fits onto the microscope stage has #6-40 UNF 
threaded holes on a 5 mm-pitch grid, enabling the chip to be secured, 
and fluid connections to be made (Figure 7.1).  Thus, in the design stage 
fluidic ports are arranged on a standardized 5-mm pitch grid.  This 
allows the same stage fixture to be used with any device.  Next, we use 
machined PEEK tubing with a compression seal to interface between the 
fluidic ports and the tubing, again, using the threaded holes to make an 
air-tight seal (Figure 7.1b,c), previously reported in Krulevitch et al. 
[165].     
7.2.2 ACOUSTOFLUIDIC CALIBRATION AND PERFORMANCE CHARACTERIZATION 
For traditional bulk acoustic wave microfluidic devices there are a 
few key operating conditions: the excitation frequency, the flow rate, the 
operating voltage, and the temperature.  In our device we have the 
additional option to use dissimilar fluids in the bypass channel to tune 
the node position.  While analytical methods (Equation 6-1) can be used 
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to estimate the resonant frequency, in practice the resonant frequency 
must be determined experimentally to take into account longitudinal 
resonances, temperature effects and variations device in fabrication.   
For this procedure a 0.01% (w/v) suspension of fluorescent 
polystyrene beads (Bangs Laboratories, Fishers, IN) and buffer solution is 
pumped through the device (usually at an average linear speed of 60 
mm/s for GEN2 devices, 20 mm/s for GEN1 devices), while stepping 
through a range of driving frequencies (approximately 1.3-1.8 MHz) at a 
constant operating voltage (between 10-20 Vpp), and capturing 
fluorescent images at each frequency step for a straight channel region 
near the device outlet.  Equilibration time after each frequency step is 10 
seconds.  The procedure is fully automated in LabView (National 
Instruments, Austin, TX), and captures a single frequency sweep data-set 
in approximately 10 minutes.  Our enhanced automation suite builds 
upon this module and allows the users to change the sweeping variable 
to determine focusing characteristics under high flow and different 
voltage conditions.   
To determine the peak frequency, the calibration bead size and 
operating voltage is chosen such that focusing is highly sensitive to the 
acoustic field.  For example, particles less than approximately 1-2 µm in 
diameter will not migrate to the pressure node, instead being entrained 
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in the secondary streaming rolls, and even at the optimal frequency no 
focusing will be apparent.  In contrast, particles that are too large do not 
serve well for calibration purposes, as they migrate to the node position 
very easily, even at sub-optimal frequencies.  For our devices calibration 
beads between 5-8 µm in diameter were most effective in determining the 
resonant frequency.  While this method is generalizable to any 
acoustofluidic device, calibration bead size will be dependent on desired 
operation voltage and efficiency of coupling between the piezoelectric 
device and the channel.  
Images are post-processed in MATLAB (The MathWorks, Natick, MA) 
by averaging intensity values along the channel length dimension, 
generating a cross-sectional bead concentration profile at each 
frequency.  When these profiles are combined into a heat-map plot as a 
function of frequency (Figure 7.2), the optimal focusing frequency f0 is 
usually apparent to the eye.  In cases where f0 is less obvious due to poor 
focusing, MATLAB chooses f0 as the maximum amplitude point. 
7.2.3 AUTOMATED SEPARATION 
After identifying chips that are effective separators, they are 
incorporated into the system depicted in Figure 7.5.  To execute the 
calibration and performance characterization described in the previous 
section, a pump, camera, and function generator were integrated into a 
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complete control system.   To achieve fully-automated fluid handling for 
precise sample separations, we incorporate additional hardware to 
manipulate samples, and monitor the separation.  The pump works in 
conjunction with valves (Valco, Houston, TX) to perform sample loading 
steps as well as system cleaning and priming steps to ensure repeatable 
operation.  Prior to processing samples, the system is cleaned and 
primed by an automated program.  The cleaning routines consist of 
flushing each fluidic pathway with copious amounts of cleaning solutions 
(bleach, ethanol, water) to ensure no cross talk between samples.  Using 
the valves it is possible to isolate each pathway, and guarantee each line 
is thoroughly flushed.  The system is primed to remove any dead volume 
in the sample lines (Figure 7.5), and is ready to perform sample 
separations.  Operating in withdrawal mode, the syringe pump and 
valves load the sample plug into the loading coil.  The sample plug is 
then infused into the chip and the flow out of the microfluidic devices is 
continuously monitored using liquid flow meters (Sensirion, AG, 
Switzerland).  Lengths of small-diameter FEP tubing (0.006” ID, IDEX, 
Oak Harbor, WA) are attached at the outlets to provide modest back-
pressure, thereby controlling the flow rate ratio between the separation 
channel outlets and increasing robustness against flow disturbances.  
Once the processed sample arrives at the output valves (3 and 4 in 
Figure 7.5), the valves switch into the collection mode. 
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7.3 RESULTS 
7.3.1 MODULAR DESIGN 
The fluidic breadboard and fixtures provides a robust platform for 
world to chip connections, and the modular design enables rapid 
changing between fluidic chips (Figure 7.1).  This configuration likewise 
allows reversible fluid connections, which seal up to 1000 psi, to be 
made quickly and reliably. 
7.3.2 AUTOMATED PARAMETER SPACE EVALUATION 
As our devices are designed to be used with various experimental 
conditions it is essential that they are thoroughly characterized prior to 
use to ensure robust operation across all situations.  To identify the 
optimal parameter combinations for high-quality separation, sweeping 
through a range of piezoceramic drive frequencies, voltages and flow 
rates is required. The control system automatically varies these tunable 
parameters and captures the relevant data—i.e., fluorescent images of 
particles flowing in the channel that are post-processed to generate the 
required measurements of particle focusing quality, frequency, and 
position (Figure 7.2, Figure 7.3). 
Figure 7.2 shows a representative frequency scans of two GEN2 
devices with good (a), and poor (b) coupling to the PZT.  After establishing 
the peak frequency, using our automated platform, we can then scan the 
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flow rate and determine the maximum processing speed for a given 
focusing efficiency (Figure 7.3).  Figure 7.3a depicts a device that 
performs moderately well, and tight focusing is observed at low flow 
speeds.  However, as the flow speed increases the focusing deteriorates 
rapidly.  Although the observed focusing position remains close to the 
predicted focusing position, the FWHM increases significantly by 
300mm/s.  In contrast the device shown in Figure 7.3b is exceptionally 
well coupled with the piezo, and shows tight focusing at flow speed over 
400mm/s. This platform assists in carefully and methodically 
interrogating all different modes of operation, determines the optimal 
conditions, and establishes the limits of focusing performance.  
With the full parameter sweep we found a slight variation of peak 
frequency with operating voltage and flow rate (Figure 7.4).  A limitation 
of our current set up is that while the operating temperature is stable 
under each condition due to the cooling fan, it is not actively controlled.  
Therefore, the variation in peak frequency is likely due to temperature 
effects.  As the temperature increases, the speed of sound generally 
increases.  Therefore we expect the effective channel width to decrease 
with a rise in temperature, and thus the resonant frequency to shift 
upwards (Equation 6-1, Equation 5-1).  As expected, we observe this 
trend in our devices (Figure 7.4).  Inconsistencies in the trend, for 
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example at high voltages and low flow speeds (15 Vpp, 60mm/s), can be 
explained by tight focusing across a range of frequencies.  As alluded to 
in our discussion of the optimal bead calibration size, when the focusing 
performance is very good, it is often difficult to determine the peak 
frequency since many frequencies show excellent focusing.  In this case, 
the low flow and high operation voltage resulted in superb focusing for a 
wide range of frequencies, thus, making it difficult to determine the true 
resonant frequency. 
7.3.3 SMALL SAMPLE SEPARATIONS 
7.3.3.1 CONTROL SYSTEM 
To achieve precise separations of finite volume samples, the flow 
sensors continuously monitor the flow out of the chip and determine 
when to start collecting sample.  The control system accurately and 
efficiently loads the sample into the sample coil.  Air bubbles are used as 
markers to denote the sample plug.  Figure 7.6a indicates the make-up 
of a typical sample plug infused through the system.  The flow sensors 
show a characteristic spike in flow when air bubbles pass through them 
(Figure 7.6b, inset).  A small amount of “leading buffer” (~35 µl) is 
required to precede the sample to ensure no flow fluctuations due to the 
first bubble transiting through different junctions occurs while the 
sample is moving through the separation chip.  Figure 7.6b shows flow 
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data resulting from a successful automated acoustic separation 
experiment.  Key features of a successful run include: 1. A gradual 
increase in flow rate in both the LPO and SPO as fluid begins to flow 
through the system 2. A sharp spike indicating the passage of an air 
bubble (the inset shows an expanded profile of a single bubble).  The air 
bubble should reach the SPO before the LPO due to the unequal flow 
from the two outlets.  3. Stable flow through both outlets between the 
two air bubbles as the sample moves through the system. 4. Gradual 
decrease in flow rate in both outlets after full sample volume is delivered 
to the system.  Problematic runs are immediately apparent from flow 
profiles similar to Figure 7.6c, where it appears the SPO became clogged 
after about 220 seconds. 
7.3.3.2 PRECIOUS SAMPLES 
The performance of the system was tested in a scenario that is 
meant to mimic processing of clinical samples, in which the exact 
physical characteristics of the particles may be unknown, and the 
available sample quantities are small.  Here, we assessed separation of 
the recently-identified golden gate virus (GGV), a snake pathogen 
infecting boa constrictor kidney cells [171].  The size of the GGV virus 
particle has not yet been measured, but since GGV belongs to the 
Arenaviridae family, it is likely of a similar size, between 100 and 150 nm 
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[172].  Raji human cells (not an infection target for the virus), and boa 
kidney cells (infection target for GGV), both at 104 cells/ml, were spiked 
with GGV (104 pfu/ml, approximate size 10 µm [171]).  These samples 
were available in low quantities, thus separation results from only one 
experimental run are reported in this work.  Figure 7.7 shows the 
percentage of Raji cells, Boa cells, and GGV collected from the SPO and 
LPO.  Cells were quantified in these experiments by counting on a 
hemocytometer and viruses were quantified by RT-qPCR.  
7.4 DISCUSSION 
We present a method to achieve system-level integration of 
microfluidic devices with macroscale equipment, enabling automated 
biological sample processing.  The modularity of this platform allows it to 
be adaptable to any continuous flow device. Three major advantages of 
this design are highlighted: 1) modularity and world-to-chip interfacing, 
2) robust characterization of device performance, and 3) automated 
processing of precisely metered sample volumes for particle separation. 
7.4.1 MODULARITY AND WORLD-TO-CHIP INTERFACING 
Our interface scheme makes for easy chip replacement and rapid 
device redesign, requiring few or no changes to other system 
components, provided chip footprints conform to the grid format.  For 
example, we have used this platform with microfluidic chips for 
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continuous-flow electrophoresis, thermal cell lysis [173], rapid mixing of 
reagents for chemical synthesis, and single-cell capture and 
interrogation.  Additionally, the world-to-chip connections are reliable 
and flexible, not showing any signs of wear after extended use.  We have 
used the same device for up to a year, and device failure usually occurs 
due to human error. 
7.4.2 COMPREHENSIVE CHARACTERIZATION OF DEVICE PERFORMANCE 
The automation platform allows full characterization of each chip 
across all relevant parameters.  With this capability we were able to 
easily identify shifts in resonant frequency.  As expected, peak 
frequencies f0 increase slightly with higher driving voltages, due to an 
increase in operating temperature and thus an increase in the speed of 
sound (Equation 5-1, Equation 6-1).  While active temperature control 
methods can be used to reduce the dependency of peak frequency on 
operating voltage, for the range of conditions used for actual separations 
the maximum variation in peak frequency with driving voltage is still 
quite small.  Peak frequencies between approximately 8 Vpp to 23 Vpp 
(approximately 25 °C to 42 °C) differ by less than 0.03 MHz (Figure 7.4). 
Additionally, this automation platform was instrumental in 
quantitatively investigating differences in coupling efficiency due to glue 
type discussed in Chapter 5.3.2 (Figure 5.6).  We have found that 
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intimate contact between the microfluidic chip and the piezoceramic is 
critical for efficient energy transfer into the fluid.  Further investigation of 
the optimal method of bonding the microfluidic chip and the 
piezoceramic will enable reliable production of high-performance devices. 
While the method presented to characterize device parameter space 
is specific for acoustofluidic devices, the automation framework can be 
applied to quantify any device.  For the specific example of acoustic 
focusing devices, the focusing quality, operating frequency, and position 
of focused particles in the microfluidic channel is measured for each 
individual device.  In addition to determining the optimal operation 
parameters, such frequency scans can assess the quality of device 
assembly (when run with polystyrene beads of known size), or to probe 
the physical properties of a previously-unknown particle type (after a 
chip has been characterized with beads). A chip with good energy 
transfer from the piezoceramic to the microfluidic channel will result in 
tight focusing at high flow rates (>280mm/s, 1 ml/min) and low voltages 
(12–15 Vpp), while those with poor energy transfer will not focus even at 
low flow rates (<100 µl/min) and high voltages (>20 Vpp).   
7.4.3 AUTOMATED SMALL-SAMPLE PROCESSING FOR PARTICLE SEPARATIONS 
The presented program is a “one-button” operation: once the 
source vial containing the sample and destination vials for fraction 
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collection are placed into the system, the “run” command initiates the 
procedure, and all steps are computer-controlled.  At the end, the 
collection vials can be removed from the system for downstream analysis 
of the separated fractions.  
Figure 7.6 shows the flow profiles measured at the SPO and LPO 
from a typical separation experiment.  First, leading buffer of at least 35 
µl is loaded to ensure stable flow before the sample reaches the acoustic 
chip.  Sample volumes less than 100 µl are not recommended for this 
system configuration, because sample dilution due to the leading buffer 
becomes excessive.  A plug of air is used at the beginning of the injection 
before the leading buffer to separate the sample plug from the fluid that 
follows, preventing mixing and dilution of sample and serving as an 
indicator to the flow sensors.  After an initial transient as fluid begins 
moving through the system, sharp spike signals in both outlets indicate 
the passage of the first air bubble.  These transients are followed by a 
long period of stable flow as the sample flows through the system, then 
another spike when the second air bubble passes, and finally an 
eventual decrease in flow rate to zero after the syringe pump stops. 
The passage of the air plugs through the flow sensors is used as 
trigger points to switch the valves to start and stop sample collection, 
thus minimizing lost sample and dilution by non-sample fluid volumes. 
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Closed-loop metering of processed sample volumes eliminates the need to 
re-program these values prior to the start of the experiment each time 
the input sample is changed.  This feature is particularly important when 
sample volume is limited, for example in the case of many clinical 
samples.  Real-time flow monitoring also assists in troubleshooting; a 
poor run (e.g., a clog forming in one of the outlets) is immediately evident 
from the resultant flow profiles, as in Figure 7.6b. 
To demonstrate the flexibility and effectiveness of acoustofluidic 
separation using the presented system architecture, GGV virus stocks 
were spiked into cell stocks and separated by processing through the 
microfluidic chip.    Figure 7.7 shows that in one experimental run, only 
about 70% of Boa cells exiting the chip were found in the LPO, compared 
with nearly 100% separation efficiency for Raji cells.  The difference in 
separation performance between the two cell types may be attributable to 
a smaller average size, lower viability, or lower single cell density of Boa 
cells as compared to Raji cells, therefore resulting in smaller acoustic 
forces.  While Raji cells were grown and harvested immediately prior to 
performing separations, the Boa cells were taken from frozen aliquots.  
To confirm or refute these suppositions, the size, density and morphology 
of Boa cells in suspension (which are normally adherent) must be 
accurately measured, an effort for further investigation.  The bulk of the 
 117 
recovered GGV exited from the SPO, indicating an enrichment of the viral 
fraction.   
7.5 CONCLUSIONS 
In order to optimize the performance of any microfluidic separation 
device, its operation must first be thoroughly characterized.  The system 
described here supports the development of rapid and automated 
protocols to do this.  Implementing complete parameter sweeps to 
characterize device operation has enabled us to identify key trends in 
building high quality acoustofluidic devices.  Applying this technique to 
other separation devices will streamline device optimization and spur 
new growth and investigations. 
While we have developed this system around the acoustofluidic 
device described in Chapter 5 and Chapter 6, this system-level design 
approach is adaptable to any other continuous-flow separation device, 
with appropriate adjustments made to account for changes in 
inlet/outlet configuration, flow rates, and inlet/outlet sample volumes.  
For example, inertial, flow-field fractionation, deterministic lateral 
displacement (DLD), and various types of electrokinetic separation 
devices can be readily incorporated.  Devices with various types of on-
chip fields (electric, magnetic) or gradients (thermal, chemical) may 
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require additional connections to the chip, or the integration of 
additional hardware, which this platform accommodates (Table 2-1).   
For successful and accurate microfluidic chip-based sample 
processing, it is critical to reliably and precisely meter, load, deliver, and 
collect the volumes of fluid as they pass through.  This precision is 
especially important when the sample volume is small (~0.1–1 ml), which 
is common in clinical or research laboratory settings [174].  Precise 
sample handling is challenging in traditional microfluidic experiments 
that employ manual withdrawal of the sample into a syringe and infusion 
into a device with no feedback of when the sample has been separated 
and when it should be collected. The presented protocol employs 
automated sample coil loading and dispensing coupled with real-time 
feedback from flow sensors to enable reproducible separations of small 
sample volumes.  By using real-time feedback during separation 
experiments, sample collection is optimized to conserve and concentrate 
sample.  Although requiring the integration of multiple pieces of 
equipment, advantages of this architecture include the ability to process 
unknown samples with no additional system optimization, ease of device 
replacement, and precise, robust sample processing. 
The presented data highlight the inherent challenges of 
engineering broadly-applicable platforms for processing a variety of 
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biological samples.  Importantly, the biological interactions can begin to 
play as great a role as the physical and mechanical effects.  However, 
these preliminary experiments also demonstrate the power and promise 
of using this system architecture for sample processing in clinical and 
research applications.  As a robust, well-characterized engineered 
system, this platform provides the capability to seek answers to new 





Figure 7.1 Fluidic Breadboard, Chip Mounting, and World-to-Chip 
Interface. Photos of (A) a GEN2 acoustic microfluidic chip (external 
dimensions of 70×9×1 mm) with attached piezo transducer wire leads, 
showing three passes of the separation channel down the chip, (B) 
custom fluidic screw fittings and machined tubing components for the 
chip-to-world interface, (C) the chip mounted to the underside of the 
fluidic breadboard using clamping fixtures, spanning an opening in the 
breadboard to allow fan cooling (D) a top view of the breadboard with 
attached tubing connections and cooling fan, and (E) a cross-sectional 
schematic of the screw fittings that interface the tubing with the 




Figure 7.2 Representative Frequency Scan. Example of frequency scan 
data for well coupled (A) and poorly coupled (B) piezo and chip.  Top row: 
fluorescent intensity of beads (red represents high, and blue represents 
low intensity).  Middle row: maximum intensity at each 
frequency.  Bottom row: location of maximum intensity, where the red 
dashed line indicates predicted focusing position, and red diamonds 




Figure 7.3 Representative Flow Scans.  The full automation system 
can be used to characterize the maximum flow rate the device can be run 
at and still achieve particle focusing.  (A) A flow scan for a device that 
has reasonable coupling between the piezo and the chip.  At low flow 
speed particles can be effectively focused at the node location.  As the 
flow rate increases the focusing becomes less tight, with the peak 
position moving farther from the predicted position, and the FWHM 
increasing. (B) A flow scan for an extremely well coupled piezo and chip.  
The focusing position and FWHM remain relatively unchanged for flow 
speeds up to 400 mm/s (1.5 ml/min).  Flow scans were run at (20Vpp).  
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Figure 7.4 Frequency, flow and voltage effects.  State plot depicting 
the peak frequency in MHz at different flow and voltage conditions for a 
single chip.  We suspect the shift towards higher frequencies with 
increased voltage is due to temperature dependent effects.  At higher 
temperatures the speed of sound increases and thus the peak frequency 
increases at higher voltages and slower flow speeds since more heat is 
generated and there is less fluid movement to dissipate it.  The gray box 




Figure 7.5 Acoustic System Configuration for Automated Separation 
Experiments.  The blue lines trace the main flow path through the 
system.  All green and black lines are 0.03” inner diameter (ID) tubing, 
and all blue and gray-colored lines are 0.01” ID tubing, with the 
exception of the holding coils, which are 0.03” ID, and the flow 
restrictors, which are 0.006” ID.  The syringes are filled with buffer, and 
the holding coils have sufficient volume (550 µl) to prevent uptake of any 




Figure 7.6 Automated Sample Processing.  (A)  Schematic of sample 
loaded in the sample coil. (B) Representative flow profile of a successful 
separation experiment. (C) Flow profile from a separation run during 




Figure 7.7 Separation Efficiency of precious small-volume samples.  
Separation results from Raji cells and Boa kidney cells spiked with 
Golden Gate Virus (GGV). Percentages collected are defined as the 
fraction of viruses or cells exiting from a specific outlet compared to the 
total amount exiting the chip.  1X PBS was used as the sample buffer 
and recovery fluid, with water in the bypass channel for all experiments.  
(n=1) 
 127 
Chapter 8 SPANNING THE SCALES- ENABLING MICROFLUIDICS AT THE 
MESOSCALE 
8.1 INTRODUCTION 
While microfluidic techniques excel at processing small volumes, 
limiting their applications to the microscale overlooks the potential to 
make an impact in a wide range of fields.  A major challenge for 
microfluidic approaches to biodetection is the “macro to micro” interface.  
This refers not only to the physical “world-to-chip” connections of a 
microfluidic device to macroscale components, and to the mismatch 
between typical clinical or analytical sample volumes (~0.1-10 mL) and 
the internal volume of microfluidic chips (~0.01-10 µl), but also to the 
statistical sampling limitations arising from bridging these size scales.  
These issues contribute to sample pre-processing and preparation being 
perceived as the “weak link” of biodetection [175].  The system described 
in this work takes major steps toward addressing these challenges.   
Recall from Chapter 3.2 the different approaches to accomplish 
large volume separations.  By optimizing specific design parameters, 
device throughput can be increased in some cases by orders of 
magnitude [118].  In Chapter 5 and Chapter 6 we describe asymmetric 
node focusing in an acoustofluidic device to increase device stability, 
allowing us to achieve efficient particle separation at higher flow speeds 
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over existing designs (Table 6-1).  However, all these methods involve 
individual devices, and improving the specific separation modality.  In 
this chapter, we seek a method that can be readily applied to a wide 
variety of devices with different operating parameters.  While we 
recognize that optimization of each individual device is necessary to 
achieve extreme throughputs, a generalizable approach to addressing the 
limited throughput of microfluidic devices can immediately improve the 
efficiency of existing devices and extend their utility.  We build on the 
platform described in Chapter 7 to enable robust, continuous, automated 
device operation.  A stable system that allows the device to operate 
continuously without user operation enables large volumes to be 
processed, as the system can continue running for extended periods of 
time.   
Our ultimate goal is to use this system to achieve automated and “smart” 
cell-culture to realize multispecies steady-state systems, which we will 
address in Chapter 9.  As a first test, we use the system to manipulate 
inert populations of particles. 
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8.2 METHODS 
8.2.1 INSTRUMENT INTERFACE  
8.2.1.1 EQUIPMENT 
While portions of the system have been discussed in previous 
chapters, for completeness, the exhaustive list of integrated laboratory 
equipment controlled by our platform is as follows:  
In line flow sensors (Sensirion AG, ZH, Switzerland) 
Selection and injection valves (Valco, Houston, TX) 
Camera (Photometrics, Tucson, AZ) 
Fraction Collectors (Biorad, Hercules, CA) 
Peristaltic Pumps (ESI, Omaha, NE) 
Syringe Pumps (Harvard Apparatus, Holliston, MA) 
Function Generator (Agilent, Santa Clara, CA) 
 
The platform is written in Labview (National Instruments, Austin, TX). 
 
Figure 8.1 shows a simplified schematic of key fluidic pathways 
and equipment.  The most commonly used configuration for culturing 
cells is presented.  During normal operation, fluid follows the black 
arrows.  Cultured cells and fresh media enter the chip, and the cells are 
concentrated into fresh media and return to the culture flask.  To take 
samples of the culture, the fluids follow the orange arrows and are 
collected using the fraction collector (not shown), and are then measured 
off-line by an automated cell counter.  Additional components that are 
not shown in the schematic: Syringe pump to clean lines and maintain 
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sterility, function generator to control acoustic field, fraction collector, 
and camera. 
8.2.1.2 ROUTINES 
The underlying framework to interface between the instruments 
and the user operations is based on “routines.”  Each desired action is 
bundled into a single step, which sequentially sends instructions to each 
piece of equipment.  While not all the equipment needs to be addressed 
in each step, the capability to do so is present.  These steps are 
concatenated into a routine.  Each routine can be saved as a text file, 
allowing users to load and edit existing routines.  With this architecture 
it is possible to achieve both simple and complex actions using the same 
framework.  Users can edit and write new routines as the system is 
running, making the system flexible and adaptable to different desired 
conditions.  Different parts of the program can send routines into a 
routine queue, which are sequentially run.  Allowing multiple callers to 
send requests to the instruments, but only having one receiver to 
interface with the equipment protects the system from trying to send too 
many commands to the equipment at once, and ensures that each 
routine will be run to completion.  Additionally, the system has “memory” 
where upon the last routine run can change the system state and future 
behavior.   
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8.2.1.3 CURRENT STATE 
To monitor the current system state a variable is continuously 
updated with the current configuration of system values, such as the 
valve positions and pump set points, and current flow readings.  This 
variable is accessible from all parts of the program.  It is continuously 
logged, and can be used to perform post-processing analysis.  
Additionally, a text field describes the current actions occurring, which is 
not only important for post processing but also for describing to users 
what the program is doing.  Furthermore, this variable aids in 
calculating system values in real-time.  For example, the volumes of 
different vessels are calculated by monitoring both the measured flow 
rates and the valve positions.  This ability has drastically improved our 
volume control, and enhanced system stability (Figure 8.4). 
8.2.2 SYSTEM ARCHITECTURE 
The automation program has three main modes: Timed 
programing, Problem detection, and Manual mode.  These modes can run 
in parallel, or the user can interactively specify what state the program 
should run in.  The most important aspect of our platform is the ability 
to monitor and automatically react to different cues and problems, which 
allow us to achieve both long-term robust device operation, and 
deterministic system manipulation. 
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8.2.2.1 PROBLEM DETECTION: REAL TIME FEED BACK 
The crucial element in making this goal a reality was to incorporate 
real-time feed back into the system to allow the program to make 
decisions without user intervention.   
We have explored various mechanisms to monitor system stability.  
For detecting flow instabilities, the flow out of each outlet is continuously 
observed using inline flow sensors.   The flow ratio is used to determine if 
one of the outlets is clogged, and the total flow is used to determine if one 
of the inlets is blocked.  The user can specify different set points used to 
define if a problem has occurred.  Additionally, as mentioned previously, 
the calculated volume in different vessels is monitored to maintain 
constant levels.  If the change in volume is greater than the acceptable 
range, routines are run until the volume is stabilized.  Furthermore, we 
have used image analysis detect debris accumulation within the chip.  At 
the outlet bifurcation fibers and debris often get caught, resulting in 
degraded separation.  However, the flow parameters remain within the 
acceptable ranges.  Therefore, we image at these points to detect changes 
in image quality and run routines to flush debris from the chip when 
debris is detected.   
To ensure consistent and stable device operation, the system 
continuously monitors key parameters.  If these values fall out of a user-
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defined acceptable range, the system automatically responds to bring the 
system back into compliance.  Upon detecting a problem, the system will 
send specific routines to the routine queue.   
8.2.2.2 TIMED PROGRAMING 
The user also has the ability to set routines to run after a specified 
amount of time.  This allows samples to be automatically collected at 
given time intervals.  Additionally, by combining different routines the 
inputs and outputs to a system can be controlled in a time resolved 
manner.  To demonstrate this capability we used a model system of 10 
μm beads (Figure 8.7).   
8.2.2.3 MANUAL MODE 
At any time the user can change the program to manual mode, 
thus turning off all automation.  In this mode the user can change any 
values and send specific commands or even full routines to the system.  
This mode essentially pauses the system, allowing the user to perform 
manual tasks such as replacing media vessels. 
8.2.2.4 SYSTEM MEMORY 
Each routine specifies a new system configuration which is applied 
after the routine is finished.  Thus, the next routine run upon detecting a 
problem is determined by the previous routine.  This allows increasingly 
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aggressive routines to be run to remedy a problem, and the most efficient 
solution to be found.  With this structure we can also implement more 
complex behavior, such as changing the normal configuration of pumps 
and valves, and allowing the system to be running or idle for varying 
amounts of time. 
8.2.3 EXPERIMENTAL SET UP FOR MODEL POPULATIONS 
Initial bead populations were generated by diluting 1 and 10 um 
beads (Invitrogen, Carlsbad, CA; Bangs Laboratory, Fishers, IN) to 105 - 
106 beads/ml in water with .05% Tween 20.  While developing and 
testing the platform various vessels were used.  We found that the most 
consistent results were obtained using a cell culture stirring flask (Bellco 
Glass, Vineland, NJ) presumably due to more efficient and consistent 
mixing as compared to standard laboratory glassware. 
To assess the effectiveness of incorporating problem detection and 
feedback from the flow sensors to achieve stable operation, we monitored 
flow rates and overall bead concentration of 10 and 1 μm particles being 
circulated through our device without introducing or removing any fluid.  
Both inputs to the chip came from the recirculating bead solution, and 
both outlets from the chip went back into the solution.  No acoustic field 
was applied during this experiment.  We expect the overall concentration 
to remain constant over time, denoted by red and blue lines in the plots 
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(Figure 8.3).  To measure population concentrations the amounts of 
particles were measured either after flowing through the chip, or directly 
from the bulk solution.  During bulk sample measurements the flow out 
of both outlets drops to 0 as the fluid bypasses the flow sensors to travel 
to the fraction collectors.  The flow resistance out of the chips was 
unequal, and during stable operation the flow out of the SPO should be 
~150 μl/min, and the flow out of the LPO should be ~80 μl/min. 
8.2.4 QUANTIFICATION 
Bead concentrations were quantified off-line by flow cytometry 
(Microcyte, Aber Instruments, Wales), or using an automated cell counter 
(Countess, Life Technologies, Waltham, MA).   
8.3 RESULTS 
8.3.1 DESIGNING SMARTER SYSTEMS WITH REAL-TIME FEEDBACK 
Figure 8.2 demonstrates the platform’s capability to address 
different problems, and take smarter, more informed steps in identifying 
the best course of action.  In this example, the system is configured such 
the LPO and SPO flow should be equal.  The flow ratio falls out of 
compliance as an apparent clog causes the LPO flow to drop, and is 
detected by the system (first red arrow).  The system attempts to clear 
the blockage by flushing all the fluid through the LPO (first green arrow).  
Then it returns to the original configuration, however, the SPO flow is 
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still much greater than the LPO flow (second red arrow), and thus the 
system runs another clean routine (second green arrow).  This time, the 
system uses a more aggressive technique, where the SPO is blocked, and 
the flow is reversed to dislodge any blockage in the LPO.  Then, solution 
is flushed out of both outlets.  This procedure is successful at 
reestablishing stable flow, and the system continues in the original 
configuration.  By establishing system memory, the platform reverses the 
flow to remove the blockage if the same problem is detected a second 
time, rather than running the same routine and potentially making 
matters worse. 
8.3.2 QUANTIFYING SYSTEM STABILITY 
PARTICLE LOSS 
A major concern is being able to operate without human 
intervention for extended periods of time.  At long time scales debris gets 
lodged in tubing interfaces and valves, which results in an overall 
decrease in system particle concentration, as well as unstable flow, as 
observed when no flow monitoring is used (Figure 8.3a).  There is 
apparent clogging in the SPO at approximately 20 hours.   
In contrast, when problem detection is enabled the flow remains 
constant for over 90 hours (Figure 8.3b), with the exception of initial flow 
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instabilities (<7 hours)c.  There are more transient spikes in the flow rate 
when problem detection is enabled, since unstable flows trigger routines 
that alter the valve and pumps parameters to try and mediate the 
problem.  For example, if a blockage is detected in the SPO the program 
will try reversing the flow to remove the blockage, and then plugging the 
LPO and flushing fluid through the SPO.  This generates the flow spikes 
seen in Figure 8.3b.  The measured bead concentration is higher than 
expected for both cases during the first ~24 hours of operation.  
However, without problem detection the measured concentration of 
beads continues to decrease over time, and this is especially true for the 
larger 10 μm beads.  In contrast, when problem detection is used the 
particle concentration stabilizes to the expected concentration. 
VOLUME STABILITY 
The clean routines are designed to address temporary flow 
instabilities, and in order to achieve this system state is changed 
temporarily from the normal mode of operation.  The aggregate effect of 
having the system in different states, combined with a systematic change 
in flow, for example, due to aging peristaltic tubing lines, can 
significantly change the volumes of the different vessels.  Figure 8.4 
shows the change in vessel volume when the volume is not being 
                                       
c During the first 7 hours of this experiment the system stability was extremely poor as 
the connections between the peristaltic lines were leaking.  This required the system to 
be stopped manually and the lines to be replaced. 
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monitored (red dashed line), and when volume is maintained at a 
constant level by automated problem detection (green solid line).  The 
black arrow indicates where the set point was changed to further restrict 
the volume change.  Upon implementing this control, the volume is 
reduced to within an acceptable range.   
8.3.3 MANIPULATING MODEL POPULATIONS 
Next, to demonstrate our capability to manipulate different species 
we use an artificial system of beads.   
8.3.3.1 MATHEMATICAL MODEL FOR POPULATION DYNAMICS 
To estimate the expected concentration of beads in each vessel the 
number of particles removed and added to the population is calculated at 
each time point. The rate of particle change in particles per time, for 𝑖 








(# 𝑜𝑓 𝑠𝑝𝑒𝑐𝑖𝑒𝑠 𝑖 𝑏𝑒𝑖𝑛𝑔 𝑎𝑑𝑑𝑒𝑑 𝑡𝑜 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑚: (𝑓𝑟𝑜𝑚 𝐿𝑃𝑂 +
 𝑓𝑟𝑜𝑚 𝑆𝑃𝑂) −
# 𝑜𝑓 𝑠𝑝𝑒𝑐𝑖𝑒𝑠 𝑖 𝑏𝑒𝑖𝑛𝑔 𝑟𝑒𝑚𝑜𝑣𝑒𝑑 𝑓𝑟𝑜𝑚 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑚 𝑖𝑛𝑡𝑜 𝑡ℎ𝑒: (𝑠𝑎𝑚𝑝𝑙𝑒 𝑖𝑛𝑝𝑢𝑡 +
𝑏𝑢𝑓𝑓𝑒𝑟 𝑖𝑛𝑝𝑢𝑡)) 
Equation 8-1 Rate species of change due to fluidics 
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We assume that the solutions are well mixed; therefore the rate of 𝑖 









, represents the bulk concentration.  The 
number of 𝑖 particles exiting the acoustic chip from each outlet is defined 
by the separation efficiency (Equation 6-2), 𝜀𝐴
𝑖  and 𝜀𝐵
𝑖 , which is dependent 
on the bead size, 𝑖, applied voltage, flow rate and flow split between the 
LPO and SPO (Equation 6-2).   The subscript A and B indicates the 
separation efficiency for particles that start at the sample inlet, and the 
buffer inlet respectively (Figure 8.5).  The volume change can also be 




.  Since both the separation efficiency and the flow split are 
defined as the proportion exiting from the LPO, the percentage of beads 
and flow exiting the SPO can be defined as 1 − 𝜀, and 1 − 𝜒 respectively.  
Rates of particles entering and exiting the chip are depicted with a 
schematic in Figure 8.5 to better illustrate the different components.  In 
the presented equations, we assume that the flow rate is the same for the 
sample and buffer inlet.  In our experiments we use a single 
multichannel peristaltic pump for both the sample and buffer inlet to 
minimize flow perturbations, therefore 𝑄 is assumed to be the same for 
both inlets.  By using different diameter peristaltic tubing, or using 
different pumps for each inlet, the flow rate of the inlets could easily be 
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controlled independently; another potential parameter to achieve 
complex behaviors. 
8.3.3.2 MANIPULATING POPULATION DYNAMICS 
First we characterize the system’s ability to continuously separate 
large and small particles by testing two different configurations. A 
summary of the different configurations and corresponding rate 
equations for the following bead experiments are described in Table 8-1. 
EXPERIMENT 1: REMOVE SMALL PARTICLES 
In Figure 8.6a, the small particles are removed from the population 
and the large particles are sent back into the recirculating solution.  In 
this experiment the flow split 𝜒 was 0.36, with more volume exiting in the 
SPO.  Thus, the overall volume decreases with time.  In this time 
approximately 430 ml of solution was processed.  Throughout this time 
the instantaneous separation efficiency of the chip remained relatively 
stable, with an average of 97% of the large particles being put back into 
the recirculating solution, while 85% of the small particles being removed 
through the chip.  As expected, over time the concentration of large 
particles increased while the small particles were eliminated from the 
system (Figure 8.6a). 
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EXPERIMENT 2: REMOVE LARGE PARTICLES 
By changing the system configuration the population dynamics 
can be manipulated.  In Figure 8.6b, a new system of beads is considered 
with a reversed configuration, such that small particles are sent back to 
the recirculating solution while large particles are removed.  In this 
experiment the flow split 𝜒 was also 0.36.  Since the separation efficiency 
of large particles is greater than that of the small particles the large 
particles are removed very quickly from the system.  The concentration of 
small particles also decreases with time since the total volume of the 
recirculating solution is increasing.  In order to further manipulate 
population dynamics it is possible to adjust the flow rates and separation 
efficiencies by adjusting the flow split and amplitude of the acoustic field. 
EXPERIMENT 3: DYNAMIC POPULATION MANIPULATION 
In our final test, we demonstrate the capability to 
programmatically change the system configuration and monitor the 
transfer of beads between two different populations (Figure 8.7).  At time 
0, population 1 contained all of the beads, in a starting volume of 60ml.  
Population 2 had no beads or volume (an empty vessel).  The system was 
programed to draw from population 1 for the sample inlet, and from 
water for the buffer inlet, and the large particle outlet was sent to 
population 2, while the small particle outlet was sent to population 1 
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(Table 8-1).  Both outlets had equal hydrodynamic resistance ensuring 
an equal flow split, thereby keeping population 1 volume constant, and 
slowly depleting it of beads. After 31 hours the valve configurations are 
changed using a timed routine.  The sample inlet now draws form 
population 2, and the buffer inlet draws from population 1, with the 
beads in the LPO being returned to population 1 and SPO returning to 
population 2 (with mostly small beads).  As expected, the trends in bead 
concentrations in both populations change accordingly, and 
experimental data mirrors predicted concentrations (Figure 8.7, lines). 
8.4 DISCUSSION 
8.4.1 ACHIEVING ROBUST DEVICE OPERATION: SMARTER SYSTEMS 
In this chapter we have outlined the necessary components to 
achieve a reactive, adaptive, “smart” platform with systems level control.  
In Chapter 7, the basic foundation for this control platform is 
established, but in this chapter three key features are implemented: 
Real-time monitoring of systems variables for program decision making, 
deterministic programing, and system memory. 
We show that monitoring output flow has the potential to 
significantly improve device operation when coupled with mitigation 
strategies to re-stabilize the flow ( 
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Figure 8.2 and Figure 8.3).  The capability to achieve robust device 
operation for multiple days is a significant step forward towards our 
ultimate goal of achieving automated cell culture.  Furthermore, this 
approach can be applied to numerous applications to enhance device 
throughput and reliability by enabling long-time operation.  Many 
microfluidic separation devices suffer from low throughput due to the 
inherently weak forces, such as dielectrophoresis, that prevent high flow 
rates or scale up.  While the majority of efforts to improve throughputs 
has been focused on specific device optimization, or parallelizing devices, 
this systems-level approach promises to be generalizable to a wide array 
of flow through devices. 
The control platform establishes sophisticated control over 
different instruments using a basic framework of routines that can be 
customized and timed.  Firstly, the interface between the instruments 
and the control system is standardized into “single steps” which make up 
routines.  This structure allows instruments to be added and removed 
from the control system in a robust and modular manner.  While the 
user has the option to access all of the different instruments at each 
step, if a command is not sent to the instrument it remains in its original 
state.  The ability to edit, and create new routines during the experiment, 
provides the flexibility to program the system as necessary.  For example, 
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users can monitor the effectiveness of different routines, and increase or 
decrease the aggressiveness of both the routine itself, and the set point 
for problem detection as necessary to maintain stable operation ( 
Figure 8.2 and Figure 8.4).   
8.4.2 CONTROLLING POPULATION DYNAMICS 
Combining timed programing with system memory different 
behaviors can be produced.  We demonstrate dynamic population 
manipulation in our final bead test in Figure 8.7.  In this test we slowly 
transfer large particles from population 1 to population 2 over the course 
of a day, then move them back to population 1.  In this manner we are 
not only using a microscale technique to influence mesoscale volumes, 
but we are doing it in a controlled and automated fashion. 
In the initial bead experiments to quantify the effect of introducing 
flow monitoring and the experiment manipulating populations of 1 and 
10 μm beads there is a transient increase in bead concentration within 
the first ~24 hours of starting the experiment (Figure 8.3 and Figure 8.6).  
We speculate that this increase is due to particles that were lodged in 
tubing interfaces and the agitation of starting a new experiment 
displaced these particles, leading to higher initial measurements. 
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8.5 CONCLUSION 
These tests collectively demonstrate the utility of real-time 
feedback for enabling robust device operation for multiple days, and 
verify our ability to manipulate multispecies systems.  While we intend to 
use our platform to achieve automated cell culture, the modularity of the 
system makes it easy to adapt to other applications.  The separation 
module can easily be replaced with other devices, or additional 
mechanisms of purification can be incorporated.  While the separation 
mechanism for our acoustofluidic device is dominated by particle size, 
the ability to use other microscale techniques opens the door to 
continuous purification or selection based on unique cellular properties, 
such as single cell density [176], deformability [177], or even a 
combination of properties [178].  One could envision using this platform 
in combination with a microscale flow cytometer [179] to continuously 
select for cells which exhibit a specific behavior and enrich the 
population over time for a the characteristic of interest for directed 
evolution applications [110].  This work establishes the basis to move 
forward and apply this platform to manipulate multispecies systems of 




Figure 8.1 Instrumentation to achieve large scale population 
manipulation.  Simplified schematic of important instrumentation, 
shown in the configuration used to culture cells.  Black arrows indicate 
direction of flow during normal operation.  Orange arrows indicate 
possible flow pathways during measurement collection.  Additional 
components that are not shown in the schematic: Syringe pump to clean 
lines and maintain sterility, function generator to control acoustic field, 




Figure 8.2 Real-time problem resolution. In line flow sensors detect 
unstable flow (red arrows) and run cleaning routines to address the 
problem (green arrows).  After the first clean routine is run (brown star), 
the flow is still not stabilized, so the program moves on to a more 





Figure 8.3 Monitoring and maintaining flow stability reduces loss of 
particles.  System data when the flow sensor feedback control is turned 
off (A) and when the feedback control is turned on (B).  Markers (top) 
describe what the system is doing.  In (A) only measurements were 
taken.  In (B) clean steps were triggered by the flow sensors (purple 
circles, orange and red squares).  Middle panel displays the flow sensor 
readings.  During measurements flow is diverted from the chip to the 
fraction collector and is viewed as a negative spike in the flow.  Bottom 
panel shows the concentration of 1 (blue) and 10 (red) um beads over 





Figure 8.4 Achieving volume control. Example of improved volume 
stability in culture vessels upon implementing volume monitoring.  Black 
arrow indicates where more stringent control parameters were set to trip 
volume control measures for the case in green.  In both cases the 





Figure 8.5 Pictorial representation of rate equations.  Particles enter 
each inlet at a rate based on the flow rate 𝑸 and concentration 
𝑵
𝑽
.  These 
samples enter the chip and are fractionated depending on the separation 
efficiency 𝜺, which is dependent on the species type 𝒊, voltage, flow rate 
𝑸, and flow split 𝝌 and whether the sample originated at the sample inlet 
A, or the buffer inlet B.  Corresponding equations for the rate 𝑹 of species 
exiting the SPO and LPO and the rate of volume 
𝒅𝑽
𝒅𝒕
 exiting each outlet are 
shown.  In this example the solution at the buffer inlet has white 
particles, under normal operation the buffer is new media with no 
particles.  However, these equations are valid for small dissolved species 
as well as particles, given the appropriate 𝜺 is used. 
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Figure 8.6 Multispecies population dynamics.  Large and small 
particle population dynamics for Experiment 1 (A) and Experiment 2 (B).  
Red and blue lines are model predictions with inputs adjusted to fit 




Figure 8.7 Using timed programing to control populations.  
Experiment 3a and 3b in Table 8-1.  Demonstration of controlled, 
programmed movement of particles between Population 1 and Population 






Table 8-1 Summary of bead population experiment setups.  The 
equations presented here are used to generate the estimates (lines) in 
Figure 8.6 and Figure 8.7. 
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Chapter 9 MANIPULATING CELL POPULATIONS 
9.1 INTRODUCTION 
The continuing threats from viral diseases highlight the need for 
new tools to study viral interactions with host cells.  Traditional tissue 
culture approaches have provided a valuable platform that gives 
investigators experimental flexibility and a high degree of control over the 
environment to test specific hypotheses. However, these techniques are 
inherently labor intensive and require manual manipulation at nearly 
every step.  Additionally, the need for serial passaging at distinct time 
points to maintain growth, distorts dynamics inherent to host-viral 
interaction in vivo.  This practice is especially limiting when trying to 
study change over time, for example, in viral evolution experiments.  
There is an unmet need for a culture platform that can operate 
continuously and independently, but maintains the experimental control 
of a traditional culture system. 
Using the platform described in Chapter 8 we aim to minimize un-
physiological disruptions, while offering additional aspects of 
experimental control.  This platform can be used to investigate cell 
population responses to a breadth of stimuli in a variety of tissue culture 
systems.  Our approach is to manipulate the environment by accurately 
controlling system inputs and outputs, while monitoring key parameters.   
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The automation platform provides precise control of the system state and 
operating parameters, with continuous monitoring of relevant variables.   
We use our flow through microfluidic acoustic size-separation device to 
retain cells in the system while removing used media and dissolved 
species in a label free and gentle manner.  Cell removal rates are 
controlled by tuning the flow rate and power supplied to the acoustic 
device.  The control platform enables the use of a microfluidic device, and 
microscale forces to process mesoscale volumes.  The system collects 
aliquots of the culture for near-real-time measurement of cell growth 
rates.  From this information, system parameters can be adjusted to 
control cell concentration.  With this system, we culture multiple cell 
types for over one month, and demonstrate the ability to manipulate cell 
concentration by adjusting operating parameters.  Next, we introduce 
DENV and SINV to human monocytes and use the system to controllably 
remove the virus.  This platform removes the need for manual attendance 
of the culture, introduces a more realistic exchange of fresh nutrients 
and removal of waste, and allows users to programmatically change 
culture parameters introducing a level of control not available to 
traditional culture systems. 
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9.2 METHODS 
9.2.1 CELL & CHIP CALIBRATION 
To determine the separation efficiency, a calibration curve was 
generated for each chip and cell type (Figure 9.1).  Aliquots from the large 
and small particle outlet were collected at different voltages at 
representative flow rates.  The flow split between the LPO and SPO was 
0.5.  Each sample was measured, and data was fit to a sigmoid curve 
using MATLAB (The MathWorks, Natick, MA).  The operating flow rate was 
not varied during experiments, allowing us to neglect the flow rate 
dependence.   
9.2.2 RATE DEFINITIONS 
Acoustic separation is an active technique, which gives us many 
parameters to vary to establish different operating conditions.  We can 
vary both flow rate and voltage to control the instantaneous separation 
efficiency, which controls cell retention and removal (“bleed”) rates.  The 
flow rate also determines the amount of new media added to the culture, 
or the “feed rate.”  When we consider the system over extended periods of 
time we can also vary the amount of time the system is perfusing the cell 
culture versus in an idle state to change the bulk feed and bleed rates. 
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The media feed rate is defined as:  
𝑭𝒎𝒆𝒅𝒊𝒂(𝒕) =  
𝐹𝑟𝑒𝑠ℎ 𝑚𝑒𝑑𝑖𝑎 𝑎𝑑𝑑𝑒𝑑 𝑡𝑜 𝑐𝑢𝑙𝑡𝑢𝑟𝑒
𝐷𝑎𝑦 ∙ 𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑢𝑙𝑡𝑢𝑟𝑒
 
Equation 9-1 Media Feed Rate 
The media bleed rate is defined as: 
𝑩𝒎𝒆𝒅𝒊𝒂(𝒕) =
𝑀𝑒𝑑𝑖𝑎 & 𝑑𝑖𝑠𝑠𝑜𝑙𝑣𝑒𝑑 𝑠𝑝𝑒𝑐𝑖𝑒𝑠 𝑟𝑒𝑚𝑜𝑣𝑒𝑑 𝑓𝑟𝑜𝑚 𝑐𝑢𝑙𝑡𝑢𝑟𝑒
𝐷𝑎𝑦 ∙ 𝑇𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑢𝑙𝑡𝑢𝑟𝑒
 
Equation 9-2 Media Bleed Rate 
Unless otherwise noted, we assume that no mixing occurs in the 
chip to calculate the media feed and bleed rate. 
The cell bleed rate is defined as: 
𝑩𝒄𝒆𝒍𝒍(𝒕) =
𝐶𝑒𝑙𝑙𝑠 𝑟𝑒𝑚𝑜𝑣𝑒𝑑 𝑓𝑟𝑜𝑚 𝑐𝑢𝑙𝑡𝑢𝑟𝑒
𝐷𝑎𝑦 ∙ 𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑖𝑛 𝑐𝑢𝑙𝑡𝑢𝑟𝑒
 
Equation 9-3 Cell Bleed Rate 
The specific growth rate is defined as:  
𝑮(𝒕) =
𝐶ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑜𝑟 𝑣𝑖𝑟𝑢𝑠𝑒𝑠





Equation 9-4 Cell Growth Rate 
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The growth rate can be calculated by comparing the measured 
concentration and the predicted concentration due to the fluidic inputs 
and outputs (Equation 8-1).  The difference between the measured and 
the predicted concentration is due to cell or virus growth (or death, if the 




(∫(𝑁0𝐺(𝑡) + 𝑅(𝑡))𝑑𝑡+𝑁0) 




(∫ 𝑁0𝐺(𝑡) 𝑑𝑡)  is the change due to growth, and 
1
𝑉(𝑡)
(∫ 𝑅(𝑡) 𝑑𝑡) is the predicted change due to the fluidic system.  In order 
to obtain a continuous function for 𝐶𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑, the measured concentration 
was fit using Matlab.  A smoothing spline function was used to estimate 
cell populations, and an exponential decay curve was used for the virus 
concentration estimations in Figure 9.6.  Since a limited number of 
points were available for the other SINV experiments an interpolant 
function was applied to calculate the growth rate for these points (Figure 
9.7).  The predicted change due to the fluidic system was calculated 
using the equations analogous to those in Table 8-1 depending on the 
system configuration at each time step.  The growth rate is calculated as 
the difference between the measured concentration and the predicted 
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concentration over a set time span, and is scaled by the total number of 
cells.  For further details see Appendix: Rate Calculations. 
9.2.3 CELL CULTURE  
We consider three different types of culture vessels: Standard T-25 
static flasks, a spinner flask with no fluidic inputs or outputs, and a 
spinner flask in combination with the automation platform.   
4G2 murine hybridoma, THP-1 human monocytic, baby hamster 
kidney (BHK) and green African monkey kidney (Vero) cells are 
maintained in cell culture media supplemented with 10% fetal bovine 
serum and 1% antibiotics in a humidified incubator maintained at 36°C 
and 5% CO2.  4G2s and THP-1s are maintained in RPMI 1640 media, 
and BHKs and Veros are maintained in DMEM media.  C6/36 mosquito 
cells were cultured in L-15 media, supplemented with 10% fetal bovine 
serum, and 1% antibiotics, in an incubator maintained at 28°C, without 
CO2 control. 
When grown in the automated culture platform the cells are 
maintained a 100 ml spinner flask (Bellco Glass, Vineland, NJ), fit with 
specialized caps which allow for direct interfacing with tubing (Kinesis, 
Saint Neots, United Kingdom).  CO2 was supplied to the spinner flask 
from a pre-mixed 5% CO2 vessel (Airgas, Radnor, PA), at a nominal rate 
of 3.5 ml/min controlled by a mass flow controller.  Cells were kept 
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suspension by stirring at 80-130 rpm in a heated water bath.  Sterility 
was maintained by filtering inlets and outlets with a 0.2 µm filter.  We 
also performed separation tests with mosquito cell line C6/36.  Mixing 
for the C6/36 was increased to over 150 rpm since they are more prone 
to clumping and adhering [180].   
To quantify viable and nonviable cells, cells were stained with 4% 
Trypan Blue mixed in a 1:1 ratio with the cell solution and quantified on 
the automated cell counter (Countess, Life Technologies, Waltham, MA).   
9.2.4 VIROLOGY METHODS 
VIRUS STOCK 
DENV serotype 2 and SINV EgAR339 was grown on Vero cells and 
then harvested and kept at -80C for future experiments.   
INFECTION 
To infect cells with DENV was added directly to the media at a MOI 
of 0.1.  In the SINV experiments, cells were infected in a small volume of 
virus under static culture conditions for 1 hour.  Then cells were washed 
at least two times with PBS to remove unattached virus.  In this manner 
we could minimize our background signal and see increases in virus 
caused by viral replication.  For the experiment presented in Figure 9.7, 
cells were infected with SINV, and then separated and seeded into 
different culture vessels: a spinner flask, a static T-25 flask, and into the 
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perfusion cell culture platform.  One sample was taken for the spinner 
and static flask using a pipette at 2 hpi.  A sample was also taken for the 
perfusion platform using the automated sampling capabilities at this 
time. 
PLAQUE ASSAYS 
To quantify viral infectivity plaque assays were performed by 
growing BHK and Vero cells to ~80% confluence on 12 or 24 well plates.  
The monolayers were then infected with serially diluted virus for 1 hour.  
The virus was immobilized using a 2% agar plug, and allowed to 
propagate for 2-4 days.  Then, cell were fixed with 10% formalin and 
stained with crystal violet.  Plaques were counted at each dilution to 
determine stock titer.  BHK and Vero cells were used to quantify SINV 
and DENV, respectively. 
PCR AMPLIFICATION 
Viral RNA was measured by performing quantitative PCR for 
conserved regions of the genome.  SINV RNA was first chemically 
extracted using TRIZOL [181].  Amplification was monitored with a 
fluorescently-labeled reporter probe.  Each amplification reaction 
contained 5 µL of sample and 20 µL of master mix, based on SuperScript 
III enzyme chemistry.  Thermal cycling was initiated with a 30 minute 
hold at 48°C for reverse transcription, then a 15-minute hold at 95°C, 
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followed by 40-50 cycles of 20 s at 94°C to denature, 10s at 55°C to 
anneal, and 30 s at 72°C to extend.   See for Table 9-1 specific primer 
and probe sequences (Integrated DNA Technologies, Coralville, IA). 
Standard curves were generated for PCR and plaque assays, 
allowing us to establish a conversion factor between PCR results and 
PFU/ml for each virus type.  In Figure 9.6 PCR results were converted to 
PFU/ml.  In the experiments establishing a multispecies system, 
individual plaque assays on each aliquot collected were performed 
(Figure 9.7), except for the spinner at 7hpi where the PCR CT was 
converted to PFU/ml. 
SANGER SEQUENCING 
Samples in Figure 9.7 (Virus Concentration plot) were purified and 
sequenced to detect changes in consensus sequence.  To obtain genome 
sequence for SINV under different conditions we followed a similar 
protocol as the PCR amplification.  SINV samples were TRIZOL extracted 
and two regions coding for the structural E2 protein were amplified 
(without a fluorescent probe).  (See Table 9-1)  Amplified samples were 
further purified using QiaQuick Nucleotide Removal Kit (Qiagen, Hilden, 
Germeny), then sent to ELIM Pharmaceutical for Sanger Sequencing 
(Hayward, CA).  Analysis was performed using Chromas (South Brisbane, 
Australia) to view chromatographs and identify multiple variants, and 
 165 
ClustalX (Dublin, Ireland) was used to compare consensus sequences.  
Protein sequences were derived from Rice and Strauss [182]. 
General cell culture supplies and chemicals and enzymes for RNA 
purification and amplification were purchased from Invitrogen (Carlsbad, 
CA), unless otherwise noted in the text.  All cell lines were from ATTC 
(Manassas, VA). 
9.3 RESULTS 
9.3.1 SEPARATION EFFICIENCY TUNING 
As expected, by varying the voltage it is possible to control the 
separation efficiency (Figure 9.1), similar to our prior work calibrating 
devices with beads in Chapter 6 (Figure 6.4).  Figure 9.1a shows 
calibration curves for 4G2 cells at three different flow rates to highlight 
the ability to modulate flow as an additional parameter to affect 
separation.  Figure 9.1b shows calibration curves for with two different 
cell types at ~250 μl/min.  We chose to fit the data to a sigmoid curve 
since we expect that below a certain voltage (or when no field is applied) 
the separation efficiency should drop to close to 0 as all the particles 
remain in their original streamline due to the laminar flow profile.  The 
separation efficiency will be most sensitive to changes at intermediate 
frequencies, and above a threshold voltage the separation should be 
maintained at maximum.  Due to diffusion and flow perturbations the 
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separation efficiency never reaches 0, even with no field applied.  The 
chip in Figure 9.1b shows a higher baseline mixing.  This is likely caused 
by a fabrication defect near the inlet in the chip used in Figure 9.1b that 
causes enhanced mixing, and thus negatively impacts the laminar flow 
profile.   
Nonviable cells are moved less efficiently into the LPO compared to 
their viable counterparts.  This improves our ability to filter out dead 
cells along with the used media.   
9.3.2 ESTABLISHING A STEADY-STATE CELL POPULATION 
To demonstrate robust automated cell culture, we cultured both 
4G2s and THP-1s in our system.  Cells were separated from spent media 
and continuously re-suspended in fresh media maintaining the 
recirculating culture, without manual manipulation.   
In comparison with traditional culture flasks, THP-1 cells can be 
maintained for extended periods, at higher cell densities in our perfusion 
platform (Figure 9.2a).  Without passaging flasks, cell death occurs after 
approximately 4 days, in contrast, when cells are maintained with the 
automated perfusion culture we can maintain cell viability (Figure 9.2b).   
Our first tests with 4G2s identify important parameters to 
establish a steady-state cell concentration.  Firstly, cells in the 
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exponential growth phase they are very sensitive to reductions in the feed 
rate as seen by the decrease in viable cells after 7 days (Figure 9.3a, red 
arrow).  Inconsistent feed rates and varied culture volume results in 
unstable cell populations between 7 and 27 days.  After ~26 days the 
feed rate is kept constant and the cell population stabilizes (Figure 9.3a, 
green arrow).  In a second test, volume monitoring is implemented to 
maintain a more stable culture volume, and the feed rate is slowly 
increased over the course of 10 days and kept relatively stable (Figure 
9.3b).  As a result, the cell population does not show the extreme 
fluctuations as seen in the Figure 9.3a. 
9.3.3 HIGH RESOLUTION SAMPLING ALLOWS CALCULATION OF GROWTH RATE 
IN NEAR REAL TIME 
Figure 9.4 demonstrates our ability to culture a variety of different 
suspension lines.  With the automation platform cell samples can be 
collected at regular intervals, and thus the growth rate can be calculated 
in near real time.  4G2 and THP-1 growth characteristics differ when 
cultured in our platform under similar conditions.  In contrast to THP-1s 
which grow quickly with 5-10 days after being introduced to the system, 
4G2s take much longer to adapt; showing exponential growth at ~ day 
15.  The 4G2s grow more rapidly than the THP-1s reaching a peak 
growth rate of approximately 0.9 day-1, while the maximum growth rate 
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for the THP-1s is 0.7 day-1.  Both these experiments were run under 
similar conditions with overall average bleed rates of <0.2 day-1, and feed 
rates of 0.6 day-1. 
9.3.4 CONTROLLING CELL GROWTH RATE 
The cell concentration is easily manipulated by changing the cell 
bleed rate. In Figure 9.5, THP-1 cells are maintained at two different 
steady states, at a high cell density (dark blue), and at a low cell density 
(light blue).  For comparison, the growth curve in a static flask is shown 
in red.  All three populations display similar initial characteristics, 
showing exponential growth within the first few days.  By continuing to 
supply the culture with fresh media the high density cells are 
maintained, with a slightly positive growth rate (Figure 9.5b, dark blue).  
For the low cell density experiment, after the initial growth the cell bleed 
rate is considerably increased to bring the cell concentration back down 
to a lower level and is then maintained at this level (Figure 9.5a, light 
blue dots and dashed orange line).  As a result the cell growth rate is 
maintained at ~0.6 day-1, which is similar to typically observed growth 
rates, .64  day-1, for this cell type [183].   
9.3.5 VIRUS REMOVAL 
Next, virus is added to the system and slowly and controllably 
removed as the media is exchanged Figure 9.6.  SINV and DENV are 
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added to two separate THP-1 culture systems undergoing perfusion (blue 
and green diamonds), and DENV is added to a static culture flask (red 
squares).  The cell concentrations in the perfusion cultures are kept 
relatively constant at ~2E6 cells/ml (Figure 9.6a, filled markers).  The 
flask culture cells reach 6E6 cells/ml at 3 days post infection (dpi), then 
die off as they have outgrown the system (Figure 9.6a, open squares).  In 
contrast to a static flask (open markers), where the virus concentration 
remains relatively constant, using our perfusion system (filled markers) 
two different types of virus are diluted over multiple days (Figure 9.6b).  
The virus bleed rate for the DENV experiment is 0.5 day-1, and the virus 
bleed rate for the SINV experiment is 0.2 day-1.  The overall virus 
depletion rate is greater than what would be expected by the fluidics 
alone (dashed lines), suggesting that other mechanisms of virus 
degradation occur when in the automation platform.  The average DENV 
growth rate is -0.4 day-1, and the SINV growth rate is -0.3 day-1, in 
contrast the static flask remains fairly constant with a growth rate of -0.1 
day-1.  These experiments did not result in a productive infection as seen 
by a lack of increase in virus concentration.   
9.3.6 ESTABLISHING A CELL-VIRUS CULTURE 
THP-1 cells are infected with SINV and infected cells are seeded in 
the automated perfusion culture, a spinner flask with no fluidic control, 
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and a traditional T-25 flask (Figure 9.7).  The cells proliferate reasonably 
well in the static flask, doubling within 1-2 days.  In the perfusion 
culture, the cell bleed rate is matched to the cell growth rate, and the 
measured cell concentration remains relatively constant.  However, the 
growth rate is considerably lower than in the flask, with a growth rate of 
0.12 days-1.  The cells in the spinner flask with no fluidic inputs or 
outputs show the least growth, remaining at a low concentration.  The 
virus successfully replicates in all three systems, resulting in an increase 
in virus at 7 hours post infection (hpi).  The virus concentration remains 
elevated in the static flask for up to 24 hpi, but in both the spinner flask 
and perfusion culture the virus titer drops by 24 hpi.  By 50 hpi all three 
vessels show similar virus concentrations. 
9.3.7 CONSENSUS SEQUENCES AND OBSERVED VARIANTS 
The E2 protein in SINV is known to be important in binding to 
susceptible cells [184,185].  Therefore, we chose two regions of the E2 
protein to amplify and sequence.  No clear changes in consensus 
sequence were observed between the different samples and the ancestor 
strain (which was used to initiate the infection).  While Sanger 
sequencing did not show clear fixed genetic differences between the 
viruses cultured under different conditions, we do see some interesting 
dynamics.   
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Firstly, at the first time point taken for the spinner and static 
flasks (one sample) mutations occur at residue 55 and 70, and two 
variants are seen compared to the ancestor virus which only shows one 
sequence (Figure 9.8).  All other samples look similar to the ancestor 
strain.  The stock virus and most of the other samples have a glutamine 
(Gln) at residue 55, and a glutamic acid (Glu) at residue 70.  The sample 
taken at 2 hpi from the spinner and the flask show an additional variant 
that has histidine (His) at residue 55 and a lysine (Lys) at residue 70. 
Next, we observe two mutants (glutamic acid and lysine) at residue 
181 in most of our samples, while our stock virus has only the glutamic 
acid variant (Figure 9.9).  Interestingly, we observe different dynamics 
between the spinner and static flask and the perfusion culture.  The 
spinner and static flask start with equal amounts of the two mutants, 
and after the first round of viral replication (7 hpi) we see a relative 
increase in the 181 lysine mutant.  In contrast, the lysine mutant 
dominates at 2 hpi in the perfusion culture and at 7 hpi the relative 
amount of the glutamic acid mutant increases.  At subsequent time 
points all three samples show similar amounts of both mutants.   
9.4 DISCUSSION 
9.4.1 CELL DISCRIMINATION  
Since the acoustic force is dependent on particle compressibility 
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and density (Equation 2-1), it is not surprising that viable and nonviable 
cells behave differently in acoustic fields (Figure 9.1).  Apoptosis, 
programmed cell death, has been shown to result in changes in 
membrane permeability, cell shrinkage and collapse of the cytoskeleton.  
Nonviable cells are stained by trypan blue, which permeates 
compromised membranes.  Yang et al. also report using acoustic fields to 
purify viable cells from apoptotic cells [98].   
Interestingly, the mosquito cell line (C6/36) shows both less 
distinction between viable and nonviable cells, as well as overall less 
efficient separation compared to the THP-1s (Figure 9.1b).  C6/36 cells 
are loosely adherent, and by vigorously mixing the cell solution in the 
spinner flask they are maintained in suspension.   We speculate that the 
C6/36s are less healthy and smaller than the THP-1s resulting in less 
efficient separation.  Additionally, these cells may be undergoing necrosis 
due to the non-ideal environment; however, the trypan blue stain is not 
sensitive enough to detect cells just beginning to perish.  This would 
result in the observed blurred distinction between the viable and 
nonviable mosquito cells in comparison to the other cell lines. 
9.4.2 PERFUSION VS STATIC 
As seen in Figure 9.2, cells in static systems die quickly upon 
exhausting the environment (on the order of a few days).  In contrast we 
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have demonstrated steady-state cell populations for multiple cell types 
extending over multiple weeks (Figure 9.4).  Not only is the cell 
concentration kept constant, but the automation platform reduces the 
manual labor associated with serially passaging cells. 
In comparison to flask-based systems, the viability is slightly lower 
in our perfusion system immediately after seeding the cells (Figure 9.2b).  
In transferring the cells to the spinner flask and setting up the different 
connections it is possible that the cells undergo more stress in 
comparison to the cells in the static flask.  Additionally, the agitation 
caused by the constant mixing and being pumped through the peristaltic 
tubing may reduce the overall viability.  However, we do not expect 
exposure to the acoustic field to affect cell viability.  Acoustic separation 
is considered a gentle separation technique. Burguillos et al. have shown 
that acoustic separation does not affect viability or induce an 
inflammation response in multiple cell types [60].  While this study 
looked at cell health after one pass through their chip (on the order of 1 
second exposure to the acoustic field), in our system the same cell has 
the opportunity to pass through the acoustic field multiple times during 
its lifetime.  However significant damage to cell health due to exposure to 
ultrasound requires long-term exposure (multiple hours), when the 
temperature is controlled and no cavitation occurs [61,62]. 
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9.4.3 CELL GROWTH KINETICS 
In general cells experience three different stages during cell 
culture: lag, log and plateau phase [186].  Initially upon being transferred 
into new growth media the cells experience a slight lag where they do not 
proliferate at high rates.  This is most apparent when thawing cells that 
had been previously frozen, or adapting to a new system, such as our 
recirculating platform.  Cells are most likely to proliferate when they are 
at a certain minimum cell density.  If cells are subcultured at extremely 
low cell densities the cell growth will lag [187].  Next, the cells enter a 
phase of exponential growth, where they grow rapidly until they have 
exhausted the available space or nutrients in the system.  Once they 
reach this point, the cells enter the plateau phase where the growth 
slows or stops.  If no new nutrients are introduced into the system the 
cells will begin to die at this phase, as seen in Figure 9.2 for the cells in a 
static flask.  In contrast, when new media is added continuously, cells 
can be maintained at this plateau phase.   
Figure 9.3 underscores the importance of keeping the feed rate 
constant to maintain a stable cell population.  The population subjected 
to fluctuations in media introduction show periods of exponential growth 
as well as severe cell death, while the population with a constant influx 
of fresh media experiences a log growth phase followed by a plateau 
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phase where the viable cell concentration is maintained.  There is a 
decrease in media introduction at 23 days in Figure 9.3b, however, we 
speculate that when cells are in the plateau phase they are less sensitive 
to disruptions in nutrient availability as their growth rate is reduced.  
This data suggests that slowly introducing fresh media as the population 
starts to enter the log phase is more effective at maintaining a stable cell 
population rather than dramatically increasing the feed rate once the 
cells are already proliferating exponentially.  Although both of these plots 
are for the same cell type, Figure 9.3a shows almost no lag phase in 
comparison to Figure 9.3b.  We speculate that the initial decrease in 
volume in for the unstable feed condition not only artificially increased 
the viable cell concentration (increased apparent cell concentration 
without cell proliferation), but also helped the cells adapt as they reached 
the minimum cell density for optimal proliferation.  For the 4G2 cells, the 
initial recommended cell density is 1x105 cells/ml [188]. 
Cells will quickly enter the plateau stage upon exhausting the 
available resources in the system.  While these cells can often be 
transferred into new growth media, to encourage them to proliferate, cell 
health deteriorates if allowed to remain in plateau phase.  For many 
suspension cell lines once they have reached a maximum density they 
begin to clump together, and cell health can be negatively affected.  It is 
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not recommended to allow THP-1s to exceed 1x106 cells/ml [183].  Using 
cells in different phases can have a significant effect on the outcome of 
experiments as the cell metabolism changes between the log and plateau 
phase.  Thus, in traditional cell culture cells must be carefully monitored 
and passaged frequently to maintain optimal cell health.  We 
demonstrate the ability to keep cells in log phase for extended periods of 
time (Figure 9.5, low cell density).  After an initial increase in cell density, 
the bleed rate is increased to keep the cell concentration below 1x106 
cells/ml, and cells maintain consistently high proliferation rates over 
many weeks.  Dramatic fluctuations that occur during each passage in 
static culture systems can affect how cells respond to subsequent 
stimuli, confounding results [10].  In contrast, this platform allows cells 
to be kept at optimal conditions, and generates a more consistent cell 
population for downstream assays. 
Since these suspension cells are not contact inhibited, the 
composition of the media is the likely the most influential factor in 
determining cell growth rate.  The cell bleed rate and feed rate can be 
adjusted independently, by altering the system configuration and varying 
the flow rate or the voltage.  Thus, we expect to some extent the cell 
growth rate and cell concentration can be manipulated independently.  
The cell density can be controlled by manipulating the cell bleed rate as 
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shown in Figure 9.5.  The cell growth rate can be enhanced by increasing 
the feed rate, or limited by decreasing the media bleed rate.  While the 
cell growth rate and the cell density are closely related, using this system 
we expect to be able to maintain a steady-state cell concentration, with 
cells growing at different rates. 
9.4.4 VIRUS REMOVAL IN PERFUSION SYSTEM EXCEEDS EXPECTATIONS 
The perfusion system enables the controllable removal of virus 
(Figure 9.6).  The virus titer in the flask based system stays relatively 
constant over time, while both perfusion systems show a reduction in 
virus concentration.  While the rate of virus removal exceeds what is 
expected by fluidic calculations alone, it is clear that the perfusion 
system is the cause for the virus removal.  This suggests there are other 
mechanisms of virus degradation and removal that are unaccounted for 
in our model.  It is likely that the increased agitation may play a role in 
increasing virus decay rate.  Additionally, the virus may be absorbing 
onto the fluidic tubing.  In previous tests with DENV it was found that 
blocking the tubing with media significantly increased virus recovery.  
While the lines should be well blocked as they constantly have media in 
them, this may still represent a significant source of virus loss in 
comparison to a static flask.  Another possible explanation may have to 
do with our cell system.  THP-1s are monocytes that are immune cells 
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that become activated upon exposure to stress and differentiate into 
macrophages.  In the spinner flasks these cells likely experience more 
stress from agitation and possibly create an environment more hostile to 
the virus.  
 While THP-1s may be infected with DENV, often it is necessary to 
introduce antibodies to facilitate the infection [189].  Similarly, THP-1s 
are not normally susceptible to SINV infection [190], as they lack 
adequate receptors for viral entry [191,192].  Therefore it is not 
unexpected that it is somewhat difficult to establish a productive 
infection in this cell system (Figure 9.6).  When the starting virus 
concentration is very high (especially in the case of the DENV 
experiment, Figure 9.6), if cells are producing a small amount virus it 
will be difficult to see this small increase over the background.  
Therefore, moving forward with SINV cells were infected for 1 hour, then 
the residual virus in the supernatant was removed.  In this manner, it 
was possible to see a small increase in virus titer upon successful 
infection of the cell culture (Figure 9.7). 
9.4.5 CELL-VIRUS POPULATIONS 
Despite the difficulty of infecting THP-1s, we successfully infected 
cells with SINV, and see a clear increase in virus titer 7 hpi (Figure 9.7).  
We expect SINV to take approximately 6 hours to complete one round of 
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replication [193].  Infected cells will start producing interferon, which can 
make neighboring cells less susceptible, thus we have found it difficult to 
maintain the infection.   As expected, the virus concentration decreases 
more rapidly in the spinner flask and perfusion culture, which supports 
the hypothesis that the enhanced agitation increases virus degradation.  
To compare virus decay rates in each system, one can compare the 
growth rates, since this measure takes into account the dilution due to 
the fluidic inputs and outputs in the perfusion platform.  The virus 
decays in the spinner flask as quickly as in the perfusion culture (Figure 
9.7c), indicating that the increased decay rate is a result of the constant 
agitation rather than fluidic dilution.  
9.4.6 RESIDUE 55 AND 70 VARIANTS: POSSIBLE STATISTICAL SAMPLING 
EFFECTS 
Since SINV takes approximately 6 hours to replicate [193], we 
expect the first time point taken (2 hpi) after washing the infected cells to 
be representative of the virus that successfully binds to the cells.  
Therefore, we expect that the sequences that appear at 2 hpi were 
present in the stock virus, but at a lower concentration.  Sanger 
sequencing can only capture viral variants that comprise approximately 
20% of the population or greater [194].  Thus, with this method we will 
likely overlook many of the low frequency variants, especially in the stock 
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virus, which is at a higher concentration than the experimental samples 
(due to the poor replication in THP-1 cells). 
The mutants observed at residues 55 and 70 were seen in only one 
of the two samples taken at 2 hpi (Figure 9.8).  The other sample taken 
at 2 hpi from the perfusion culture looks similar to the ancestor strain 
(not shown).  Since all the cells in this experiment were infected together 
then used to seed different culture vessels, we would expect both 
measurements taken at the earliest time points to be very similar.  This 
suggests that the difference between these samples may be due to 
statistical sampling errors, as the total number of virions being assayed 
is very small. While the mesoscale perfusion culture does allow for a 
much larger virus population since the total culture volume is an order 
of magnitude larger than the static flask, only 5µl of purified RNA is 
amplified and sequenced for each sample.  Based on a concentration of 
2000 PFU/ml, we would expect on the order of 10 viable virions in each 
sequencing reaction.  These results highlight the necessity of not only 
achieving larger culture volumes to encourage viral diversity, but also 
using methods that can interrogate that diversity.  By concentrating the 
purified RNA, a larger number of virions can be interrogated.  
Additionally, using strategies employed in digital PCR to partition the 
sample and sequence each aliquot can help assess the frequency of 
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different mutants.  Of course, the most informative method to probe viral 
diversity would be to perform deep sequencing on many virions, to 
identify low frequency mutants. 
The mutants observed at residues 55 and 70 have previously been 
observed, suggesting that their presence in the stock virus is not 
unusual.  These particular residues are important in binding to host 
cells, and conferring virulence.  Multiple investigators have observed an 
increase in neural virulence with the glutamine to histidine mutation at 
residue 55 [184,195].  Lysine at residue 70 is common in laboratory 
strains as an adaption to cell culture [196].    
9.4.7 DIFFERENT VIRAL EVOLUTION DYNAMICS IN PERFUSION VS CLOSED 
SYSTEM CULTURES: RESIDUE 181 VARIANTS 
Residue 181 is part of the receptor binding protein [185], and it is 
expected that we will see mutations in this region as the virus adapts on 
different host cells.  The stock virus was produced on Vero cells, while in 
this experiment virus was grown on THP-1s.  The stock virus has 181 
glutamic acid, while other measured samples show both 181 glutamic 
acid and 181 lysine.  Colleagues have observed a similar transition from 
181 glutamic acid to 181 lysine upon changing host cells from Veros to 
primary neurons [156]. Since both mutants are observed at both 2 hpi 
measurements this suggests that the 181 lysine mutant binds more 
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successfully to THP-1 cells, thus we see a relative increase in the 181 
lysine mutant in comparison to the ancestor strain. 
We observe an increase in glutamic acid mutants in the perfusion 
platform, while we see an increase in lysine mutants in the closed 
systems (static flask and spinner) at 7 hpi.  We offer two possible 
hypotheses for this difference.  Firstly, the glutamic acid mutants may be 
more fit in the recirculating environment, possibly achieving stronger 
binding to cells, and thus are less likely to be removed from the system.  
In contrast, in the closed systems the binding may not be as important 
since the virus is not being removed.  Another possible explanation is 
that it is advantageous for the viral mutant spectra to be more diverse, 
thus in the perfusion system where initially the lysine mutants dominate, 
at the next time point the glutamic acid mutants increase to balance the 
population.  In contrast, the spinner and static flasks start with relatively 
equal number of mutants.  After 7hpi both mutants persist in all three 
cultures, supporting the argument that a more diverse mutant spectrum 
is beneficial.  However, further longer-term and more comprehensive 
experiments are required to validate these hypotheses and ensure that 
the observed phenomena are repeatable rather than an artifact of small 
sample sizes.   
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9.5 CONCLUSION AND OUTLOOK 
Using this platform we can carefully monitor culture inputs and 
outputs, allowing us to precisely control the culture microenvironment.  
By carefully controlling and monitoring the culture platform we can 
investigate differences in growth kinetics between cell types (Figure 9.4).  
Purposefully manipulating the system allows us to both probe cell 
stability (Figure 9.3), as well as control the cell kinetics (Figure 9.5).   
This platform combines automation and robustness with the 
flexibility to adjust parameters and add components.  It can be 
immediately applied to reduce the labor associated with maintaining 
cultured cell lines, improve cell health, and generate more consistent 
cells for downstream applications.   
By establishing a continuously perfused cell-virus culture we 
demonstrate different virus dynamics.  SINV and DENV are slowly 
removed from the culture in comparison to a static flask culture where 
the virus concentration stays relatively stable over time (Figure 9.6).  In 
our perfusion culture, we observed SINV being produced at a slightly 
higher rate initially, and then being eliminated more quickly than an 
analogous static flask based systems (Figure 9.7).  However, since the 
SINV growth dynamics in the perfusion system are very similar to the 
observed dynamics in a spinner flask, this suggests that any differences 
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from the static flask may be induced by increased agitation rather than 
the perfusion system.  We also investigate changes in viral consensus 
sequence with different culture conditions.  While we do not see any 
mutations going to fixation, we do see the appearance of different 
mutants in comparison to the stock virus (Figure 9.8 and Figure 9.9).  
While this work is very preliminary, it suggests that these methods can 
be used to probe viral evolution.  Further work establishing a steady-
state virus population and using cell-virus pairs that establish more 
productive virus infection is required to realize enhanced viral evolution 
studies.  
As a mesoscale technique this platform has the potential to probe 
virus evolution in a more robust manner.  Since our system is roughly 
one to two orders of magnitude greater in volume than the typical vessel 
used to perform virus evolution studies (well plates, T25 flasks), we 
would expect the genetic diversity within the virus population to be 
correspondingly larger.  Therefore, we expect results to be more 
consistent between experiments, as important mutants (i.e. high fitness) 
are more likely to be generated in every experiment, simply based on the 
number of mutants being generated at any given time.  However, our 
results highlight the importance of using corresponding measurement 
techniques that can probe the large genetic diversity in a robust manner 
 185 
(Figure 9.8).  We observe different viral evolution dynamics between virus 
grown in the perfusion platform and closed systems, suggesting that the 
mode of culturing cells and virus can affect the viral mutant spectra 
(Figure 9.9).   
Using this system it is possible to simulate the innate immune 
response by nonspecifically removing viruses, as well as add other 
components, such as an anti-viral regime.  Furthermore, insight gleaned 
from this platform can be immediately relevant for industrial vaccine 
production systems operating under similar suspension, perfusion 





Figure 9.1 Cell Calibration Curves. Calibration curves to determine the 
separation efficiency,𝜺, as a function of voltage.  Green markers are for 
viable cells, and red markers are for nonviable cells.  The experimental 
data is fit to a sigmoid curve.  (A) Separation of 4G2 cells at different flow 
rates.  Since experiments are run between 200-230 μl/min the 
calibration curve for 225 μl/min was used in calculations. (B) Calibration 
curves for THP-1 and C6/36 cells, at 225 μl/min.  Calibration curves in 




Figure 9.2 Growth curves in static flask and perfusion platform. 
Comparison of (A) growth curves and (B) viability in a standard T25 flask 
our recirculating culture platform for THP-1s.  Cells in both systems 
show an exponential growth within the first 4 days.  After 4 days the cells 
in the flask begin to die as they overgrow the flask.  However, the cells in 
the recirculating system are maintained at a high cell concentration, and 




Figure 9.3 Cell Sensitivity to Feed Rate.  Growth curve and feed rate 
for two different experiments with 4G2 cells.  (A) The feed rate varies 
throughout the experiment and as a result the cell population fluctuates.  
Reduction in feed rate contributes to cell death (red arrow).  After the 
feed rate is steadied the cell population stabilizes (green arrow).  (B) 
When the feed rate is kept relatively constant the cells population 
remains fairly stable, showing exponential growth at ~15 days.  
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Figure 9.4 Cell Growth Kinetics.  4G2 and THP-1 growth 
characteristics differ when cultured in the platform under similar 
conditions.  (A) THP-1 cells grow quickly immediately upon being 
introduced to the system (blue), while 4G2 cells take much longer to 
adapt; showing exponential growth at ~ day 15 (green).  (B) The growth 
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rate is calculated with a moving window of 1 day.  When the cells enter 
the log growth phase the growth rate increases sharply (5 days blue, 15 
days green).  When the cells enter the plateau phase the growth rate 
decreases.  The overall average cell bleed and media feed rate are similar 




Figure 9.5 Manipulating Cell Growth.  (A) THP-1s are maintained at 
two different cell densities (low light blue, and high dark blue), by 
adjusting the cell bleed rate.  For reference the growth curve from a static 
flask is shown (red).  (B)  By keeping the cells at a low cell density, cell 
proliferation is encouraged, and cell growth is sustained at a high level 
(light blue).   
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Figure 9.6 Controllable Virus Removal.  The (A) viable cell 
concentration and (B) virus titer for three different cell-virus systems.  
The open markers are in a static flask, while the filled markers are in the 
perfusion platform.  (A) While the cell population fluctuates immediately 
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after infection, the perfusion platform is able to maintain a reasonably 
stable cell concentration (blue diamonds) in comparison to the static 
flask (red squares) in the DENV experiments.  The red dotted line is to 
guide the eye for the static condition.  (B) Both DENV and SINV virus are 
slowly removed from the system using the perfusion platform.  The 




Figure 9.7 SINV infection.  Cells were infected with SINV at a MOI of 
7.5 and then seeded in three different systems: a spinner flask connected 
to our automation platform (blue circles), a spinner flask with no fluidic 
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control (green circles), and a static flask (red squares).  The cells are 
successfully infected and virus titer increases after 7 hours.  However, 
the virus titer decreases rapidly within 2 days.  These samples were 





Figure 9.8 Chromatograph of ancestor and 2 hpi SINV sequences. In 
the ancestor strain, there are no apparent variations at these residues 
(55 Gln, 70 Glu) in the E2 protein.  However, in the sample taken 
immediately after washing the virus, we see 55 His (CAT) and 70 Lys 




Figure 9.9 Variants in samples at residue 181. The stock ancestor 
strain shows only 181 Glu (GAA), while measured samples show both 
181 Glu and 181 Lys (AAA).  Since we see both variants at 2 hpi we 
expect that both are present in the stock virus.  After the first round of 
viral replication (7 hpi) an increase in the relative amount 181 Lys is 
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observed in the spinner and static flask samples, while an increase in 
181 Glu is observed in the perfusion culture.  Subsequent time points 
(24, 50 hpi) show both mutants at relatively equal amounts for all 
samples.  One sample was taken at 2 hpi prior to seeding the spinner 






Table 9-1 Sequences used for PCR amplification of DENV and SINV. 
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Chapter 10 CONCLUSIONS AND OUTLOOK 
By operating at small lengths scales, different physical phenomena 
are accessible to microscale devices as compared to bulk technologies.  
These length scales are immediately compatible with cellular systems, 
and as a result have been used extensively to manipulate [158], process 
[197] and mimic cellular systems [8].  Using microfluidics, cells can be 
separated by inherent physical properties, without the addition of 
molecular labels minimizing disruptions to the cellular state.  These 
properties have further been correlated with a variety of different disease 
states [198,199], allowing specific subpopulations to be selected for.  
These techniques have the potential to be applied to a wide range of 
applications, from precise isolation of rare species, to larger scale sample 
processing.  For successful implementation device reliability is of 
paramount importance in small sample separations, while sample 
throughput becomes a greater concern when dealing with large volumes.  
Thus, robust, fast methods are preferred.  The most obvious course of 
action to improve device throughput is to optimize existing designs.  On 
the other hand, other techniques such as parallelization and increasing 
the length of time a device can operate for can also improve sample 
throughput.  While the field is constantly inundated with new devices, 
less effort has been dedicated to integrate novel and sophisticated 
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devices with existing infrastructures.  This thesis addresses these 
development gaps by first demonstrating a novel design which simplifies 
acoustofluidic device operation and increases throughput, and then 
developing an automation platform that enhances device operation on 
both small and large scales.   
Next, we move on to apply this platform to cell culture.  
Microfluidic culture platforms have been successful at generating 
microenvironments that can mimic in vivo conditions [8].  However, these 
systems are somewhat limited by the typically small volumes, making it 
difficult to interface with existing benchtop procedures.  On the other 
hand, microfluidic separation methods (some of which operate at the ml 
scale) are less frequently applied to cell culture.  These techniques have 
incredible sensitives and can be used to select specific cells from a 
population, for example in the case of directed evolution [110].  We see 
an opportunity to use microscale methods to precisely manipulate cell 
systems.  We focus on developing a platform for continuous automated 
cell culture.  This platform has the opportunity to make a significant 
impact in virus evolution studies which are limited by small volume 
studies since the mutant spectra is closely related to the population size.  
By working with meso-volumes we allow more mutations to occur, and 
increase the chance that key variants will be generated.  As a first 
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demonstration, we infect cells in our system with SINV. 
10.1 NOVEL ACOUSTIC DESIGN: TRANSPARENT WALL 
Acoustophoresis is an ideal biocompatible [61] separation 
technique since they can regularly achieve moderate to high throughputs 
[1], the effective “pore size” can be tuned [101], and the materials are 
extremely robust, allowing for continued use.  To fractionate samples, 
bulk acoustic wave resonators generate a standing wave in the channel 
causing particles preferentially migrate to pressure nodes.  In this 
manner, node locations are constrained by the channel geometry, 
limiting the flexibility of device operation.  To address this restriction, we 
demonstrate engineered node positioning using a thin silicon wall to sub-
divide the channel. 
10.1.1 MAJOR CONTRIBUTIONS 
We establish acoustic focusing in spite of a thin silicon wall, thus 
confirming our “transparent wall” approach to acoustofluidic design.  
First, we quantify the effect of wall thickness on focusing.  We find that 
thick walls significantly inhibit particle focusing, suggesting that the 
acoustic wave cannot propagate through.  The focusing characteristics 
show a greater variability with thicker walls, whereas devices with thin 
walls consistently perform reasonably well (Figure 5.4).  From this study, 
we conclude that devices should be fabricated with the thinnest possible 
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walls to achieve high quality particle focusing and for reliable device 
performance. By incorporating these design guidelines into our next 
generation of devices, we show improved focusing across all devices.  By 
moving the wall location, the node can be placed arbitrarily in the main 
separation channel, and devices with different wall locations show 
similar high performance (Figure 5.5).  Our unique design results in a 
bypass channel that is completely isolated from the separation channel, 
allowing us to use different fluids in this channel without contaminating 
or affecting our samples.  By using fluids with different densities, we can 
manipulate the propagating wave and shift the node position in situ 
(Figure 6.1).  Furthermore, we find a simple analytical equation can 
estimate node location and peak frequency with reasonable accuracy 
(Equation 6-1, Figure 6.3).  Thus predictable node shifting can be 
implemented in our device, and focusing characteristics can be estimated 
with Equation 6-1.  These results validate using acoustically transparent 
walls as a robust and versatile option for acoustofluidic design.  Beyond 
increasing the flexibility of device operation, this technique further 
simplifies device operation, which allows us to achieve high throughput 
focusing (Figure 5.7) and separation for beads (Figure 6.5) and cell-virus 
mixtures (Figure 6.6). 
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Moreover, this work represents a significant deviation from 
common practices in designing acoustic resonators.  Silicon walls are 
traditionally assumed to reflect acoustic waves. This work supports the 
opposite hypothesis: Waves can be transmitted through thin materials, 
even if based on bulk material properties the wave is expected to be 
reflected. 
10.1.2 FUTURE WORK 
This work underscores the complexity of acoustic force generation, 
and the physics that occur at this scale.  For instance, the acoustic wave 
generates secondary streaming flows around the pressure nodes 
[200,201].  However, in our device we expect the wall to significantly alter 
this secondary flow.  A more thorough investigation of the contributions 
from acoustic streaming in these devices (e.g. by micro-particle image 
velocimetry) promises to help elucidate this phenomen.  Additionally, 
further examination into the hypothesis that the thin walls vibrate at 
frequencies different than the overall channel resonance will help inform 
acoustic device theory and practical limitations of the “transparent wall” 
design method.  The data generated from our device can provide valuable 
empirical information about acoustic field interactions. 
This device can be readily applied to any application where micron-
size particles must be separated.  The ability to use acoustic focusing at 
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high flow rates opens doors to applications typically beyond the scale of 
microfluidic devices.  While we intend to continue our work in using it to 
manipulate cell-virus samples, we expect that this technology can be 
used in a wide range of different fields, especially those concerning large 
volumes, or unknown samples.  For example, this device could be 
coupled with others for continuous generation and purification of 
fabricated nanoparticles.  Additionally, it could be used to remove large 
cell-sized particles and enrich viral content from samples such as serum 
(clinical), wastewater (industrial), and sea-water (environmental) to 
facilitate downstream processing and detection.  We are currently 
investigating using this device to remove debris from samples for malaria 
vaccine production.   
Beyond immediate applications, the high flow capability allows 
novel separation mechanisms to be explored.  For example, inertial 
effects can start having an impact.  We have seen limited evidence of 
inertial focusing within our devices, and are currently exploring methods 
to couple acoustic and inertial focusing to generate a novel mechanism of 
particle manipulation. 
10.2 GENERALIZABLE MICROFLUIDIC PLATFORM 
A major deterrent to adopting a new system is the effort required to 
troubleshoot and integrate it with existing systems.  Moreover, it is often 
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more desirable to use the same method to process a variety of different 
samples, rather than having specialized protocols for each specific 
sample.  Therefore, we developed a generalizable platform that can be 
used with most flow through separation devices, to process both large 
and small volume samples. 
10.2.1 MAJOR CONTRIBUTIONS 
In Chapter 7 we outline the components necessary for modular 
device design, acoustofluidic device characterization, and reliable 
processing of precisely-metered analytical-scale volumes.  While we 
recognize that it is unlikely that there will be a widespread shift to using 
our specific mechanisms of interfacing with microfluidic chips (Figure 
7.1), the design guidelines presented in this thesis should serve as a 
starting point towards increasing design efficiency.  Using compression 
fittings has been highly successful as a robust method to make world-to-
chip connections [135], and industry leaders such as Micronit frequently 
use this method.  Consistently designing fluidic chips to fit a given 
footprint, having defined fluidic inputs and output positions has been 
highly beneficial in allowing us to use stage fixtures interchangeably 
between devices.  Creation and implementation of standardized practices 
such as these across the field will streamline development, encourage 
collaboration and spur adoption of microfluidic technologies.   
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The platform developed in Chapter 6 and Chapter 7 for both 
precise sample separations and long-time operation has likewise been 
designed to be compatible with a variety of different devices.  Together 
with the standardized world-to-chip connections, the control platform 
adds further flexibility allowing us to easily control many different pieces 
of laboratory equipment.  Beyond using the control platform in 
conjunction with a separator to control population dynamics (Figure 8.6 
and Figure 8.7), it provides the framework for achieving general 
laboratory automation.  We have used this platform to accomplish 
dielectrophoretic separation, single-cell capture and interrogation, and 
inertial focusing experiments.   
Similarly, the automation framework presented to sweep device 
parameter space can be applied to any type of device and is not limited to 
acoustophoretic techniques.  By facilitating device characterization, 
important design parameters can be identified more quickly, making 
device development more efficient.   
10.2.2 FUTURE WORK 
The system functionality would be immediately improved by 
incorporating an in-line counter to measure different populations.  In 
this manner, a feedback control scheme could be developed to change 
the population dynamics in a deterministic way, rather than relying on 
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estimations based on flow and separation efficiency (Equation 8-1, Table 
8-1). 
We aim to further develop this platform to a deployable system.  
Most of all, we expect to further refine the software development protocol 
to establish a standardized method to implement new equipment.  As a 
research scale technique, we believe this platform would have the most 
impact if it is adapted to an open-source platform and make the code 
widely available.  Having the automation framework in place with well-
defined methods to customize it for each specialized application makes 
these methods accessible to researchers with limited resources for 
automation platforms.  As demonstrated in this thesis, having 
automation capabilities is not just a luxury, but can help uncover hidden 
associations (Figure 5.6), identify trends (Figure 7.4), and enable 
pioneering studies (Chapter 9).  
10.3 MANIPULATE CELL SYSTEMS 
Standard laboratory cell culture gives investigators experimental 
flexibility and a high degree of control over the environment to test 
specific hypotheses.  However, these methods are labor intensive, and 
require manual manipulation at nearly every step, resulting in 
experimental variability.  Additionally, the need for serial passaging at 
distinct time points to maintain growth distorts cell dynamics from 
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inherent steady-state in vivo conditions.  This is particularly troubling 
when considering multispecies systems, such as viral infections.  On the 
other hand, microfluidic devices present the opportunity to precisely 
control and measure the cell culture environment [142].  However, 
microscale techniques are difficult to integrate into existing work flows 
due to the stark size differences.  We bridge these scales and retain the 
benefits of each, by using the automation platform developed in Chapter 
7 and Chapter 8 with the acoustofluidic separation device described in 
Chapter 5 to achieve continuous perfusion cell culture on the benchtop.  
We envision that this platform can be used for revolutionary studies on 
viral evolution by achieving a steady-state cell-virus culture, and using 
larger volumes than traditional plate based assays, allowing for a larger 
viral population and thus a greater number of mutations. 
10.3.1 MAJOR CONTRIBUTIONS 
We have developed a continuous-flow culture platform that 
minimizes un-physiological disruptions, while offering additional aspects 
of experimental control.  Using this platform, we have achieved steady-
state cell populations with multiple cell types for over a month.  Overall, 
we have demonstrated the ability to use a microfluidic device to change 
large scale population behavior.  Specifically, we can use the platform to 
study cell growth kinetics (Figure 9.4), and even alter cell growth 
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behavior (Figure 9.5).  Additionally, we demonstrate controllable removal 
of virus from the system (Figure 9.6), and investigate virus dynamics 
(Figure 9.7 and Figure 9.9). 
10.3.2 FUTURE WORK AND OUTLOOK 
This work has resulted in a robust platform that has the potential 
to control cell-virus systems.  However, to increase control and maintain 
a more stable culture environment measuring additional culture 
parameters can immediately improve culture stability.  For example, 
including pH and dissolved oxygen monitoring.   
As a first demonstration of probing viral evolution, we looked for 
changes in SINV consensus sequence after being grown in our platform.  
While results are encouraging, and hints at possible differences in viral 
evolution dynamics in our system compared to closed culture flasks, this 
study is incredibly limited and further long-term studies which 
incorporate next generation sequencing methods are needed to verify 
differences in evolution dynamics.  We have the opportunity to delve into 
the realm of virus evolution and intend to continue our work in studying 
cell-virus steady state systems.  This platform can be used to more 
closely mimic in vivo host-virus dynamics to determine how a virus 
population adapts.  By increasing the variety of cell lines and viruses 
that can be cultured in our system, innovative studies probing host 
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susceptibility, and infection mechanisms are possible.  Therefore, a high 
priority item is adapting this platform for adherent cells.  Since the 
automation platform is designed to work with any flow through 
separation device we can easily exchange the acoustophoretic separator 
for a device that can be used with microcarrier beads for cell culture.  We 
are currently investigating an inertial device to accomplish this.   
This platform parallels small-scale bioreactors used for optimizing 
production scale methods.  Therefore, this platform can be used to probe 
how viruses behave in perfusion cultures to inform vaccine processes.  
Overall, we are on the cusp of using this platform to answer pressing 
questions in virology. 
While other perfusion culture systems exist, our system is unique 
in that it marries a microfluidic device to a mesoscale culture system.  
Moving beyond cell-virus studies, this platform represents an 
opportunity to use the precision of microfluidics to perform large scale 
cell culture.  Combined with improvements in device engineering, one 
can envision a system that continuously measures and sorts cells based, 
not only on size, but different cellular states in a gentle and label-free 
manner.  For example, devices already exist to probe a variety of single 
cell physical properties, including density [176], deformability [177], 
electric [202] and acoustic [178] properties.  Further development of the 
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field will result in microscale flow cytometers and sorters based on these 
physical properties.  Combining our system with these cytometers will 
allow us to both continuously measure and select for cells which exhibit 
a specific behavior, and enrich the population over time for the 
characteristic of interest. We can imagine continuously monitoring a 
system and selecting for cells that are capable of clearing and eliminating 
a broad range of viruses.  In this manner we can identify key pathways 
that confer resistance, as well as open new pathways for therapies.  With 
our automation platform, tight control can be maintained over 
populations, and we will achieve single cell, time-resolved granularity at 
the population level.   
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APPENDIX       
COMSOL ACOUSTIC-SOLIDS MODEL 
The fluid regions were modeled using pressure acoustics, and the 
solid silicon wall was modeled as solid mechanics.   
The fluid domains are governed by the Hemholtz wave equation for 








Where 𝑝 is the pressure, 𝑐0 is the speed of sound in the medium, 
and 𝑡 is the time variable.  This equation is derived from the conservation 
of mass, momentum and energy, allowing for small variations in the 
pressure field.  The boundaries defined by the silicon and glass walls are 
assumed to be hard sound boundaries (infinite acoustic impedance), 




𝛻𝑝) = 0 
Where 𝒏𝑎is the vector normal to the wall, and 𝜌0 is the density of 
the fluid.  We assume constant fluid density in this model.   
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The thin silicon wall is modeled as a linear elastic material: 
−𝜌𝜔2𝒖 − ∇ ∙ 𝜎 = 𝐹𝑣 
Where 𝜌 is the density  of silicon, 𝜔 is the angular frequency, 𝒖 is 
the displacement, 𝜎 is the stress, 𝐹 is the force, and 𝑣 is Poisson’s ratio 
for the material.  The top and bottom of the wall are fixed: 
𝒖 = 0 
To couple the acoustic to the mechanic domain the pressure field 
from the fluid induces a stress on the wall: 
𝜎 ∙ 𝒏 = 𝑝𝒏 





𝛻𝑝) = −𝑛 ∙ 𝒖𝒕𝒕 
Material properties were taken from Comsol for pure solutions and 
solid silicon. Glycerol properties were based on the density of mixed 
solutions at 40ºC [203] and the speed of sound was estimated from the 
density using data from [204]. Properties of ethanol mixtures were 
estimated based on [205], [206] and [207].  
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RATE CALCULATIONS 
Estimated concentration at time 1 (𝑡1) 
𝑑𝑁
𝑑𝑡













To calculate the growth rate (rate of change over specified time 
period) [208] 














S1: population size at beginning of observation period.  S2: 
population size at end of observation period, 𝑇𝑜𝑏𝑠: period of observation 
(time), 𝑇𝑈: unit of time  
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